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ABSTRACT OF THE DISSERTATION 
EVALUATION OF A BRIEF INTERVENTION TO IMPROVE HUMAN 
PAPILLOMAVIRUS-RELATED AWARENESS, KNOWLEDGE, AND ATTITUDES 
AMONG ETHNICALLY AND SEXUALLY DIVERSE COLLEGE STUDENTS 
by 
Sharice M. Preston 
Florida International University, 2018 
Miami, Florida 
Professor William Darrow, Major Professor 
Human papillomavirus (HPV) is a preventable infection responsible for anogenital and 
oropharyngeal cancers, as well as genital warts. Two safe and effective vaccines are 
recommended for adolescents and young adults to protect against HPV infection. Both are 
severely underutilized. Sexual and ethnic minorities are disproportionately affected by 
HPV infection and its sequelae. The goals of this study were to (1) assess baseline 
differences in HPV-related awareness, knowledge, and attitudes between men and women, 
and (2) evaluate the differential efficacy of a brief, educational HPV intervention among 
ethnically and sexually diverse college students. Students attending undergraduate courses 
from 2015 to 2017 participated in a brief, tailored, classroom intervention designed to 
improve HPV-related awareness, knowledge, and attitudes. These outcomes were assessed 
immediately before and following an evidence-based educational presentation about HPV 
risks, outcomes, treatments, and prevention. At baseline, 84% of participants (N=386) had 
heard of HPV; 28% of men and 55% of women reported receiving ≥1 dose of HPV vaccine. 
Vaccinated women were seven times more likely to report favorable attitudes than 
 viii 
 
unvaccinated women (RR=7.1, CI[3.3-15.5]). Hispanic participants had more positive 
attitudes toward HPV vaccination (62% vs. 44%; P=0.009) and were more willing to 
become vaccinated (66% vs. 46%; p=0.02) than non-Hispanic participants at baseline. Gay 
and bisexual men (92%) were more likely than heterosexual men (68%) to have heard of 
HPV, to receive any doses of HPV vaccine (37% vs 19%), to view HPV vaccination 
positively (58% vs 39%), and more willing to be vaccinated (86% vs 39%; P<0.05). 
Following the intervention, participants’ HPV knowledge improved by 41%. Baseline 
disparities between genders, ethnicities, and sexual orientations dissipated at post-test. 
Participants rated the intervention components and overall experience positively (93-97%). 
In summary, significant disparities exist in HPV-related awareness, knowledge, and 
attitudes between students of different genders, ethnicities, and sexual orientations. 
Tailored and targeted educational interventions can be a successful method for diminishing 
these disparities, encouraging HPV vaccination, and relieving the burden of HPV and its 
adverse outcomes. 
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CHAPTER I 
Introduction 
Health promotion has been defined by the World Health Organization as “The 
process of enabling people to increase control over, and to improve, their health. It moves 
beyond a focus on individual behavior towards a wide range of social and environmental 
interventions.”1 In the same vein, disease prevention specifically focuses on population- 
or individual-level prevention efforts aimed at reducing the incidence and burden of 
diseases and their associated risk factors. Health promotion and disease prevention often 
share goals, and both often utilize education and educational interventions as a means for 
reaching specific goals.2  
Historically, interventions to prevent sexually transmitted infections (STIs) were 
not a priority among health promotion professionals. STI control was mainly the concern 
of military and private physicians in the United States (U.S.), with early behavioral 
efforts targeting high-risk groups, such as prostitutes and military personnel.3 Behavioral 
approaches to prevention became secondary to the biomedical model in the early 1900s 
with improvements in diagnostic techniques, discovery of antibiotics and treatment with 
heavy metal compounds, and epidemiological methods.4 With the discovery of 
autoimmune deficiency syndrome (AIDS) in the early 1980s, the biomedical model was 
viewed as only a part of the solution; early detection and no cure offered little to prevent 
transmission of the deadly disease.4 Modifications of sexual behavior was increasingly 
acknowledged as not only a potential preventive tool for curtailing STIs, but essential for 
the success of the biomedical interventions as patient and provider behaviors surrounding 
screening, diagnosis, and treatment were scrutinized.4    
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In 1990, the Department of Health and Human Services released the report 
“Healthy People 2000,” a strategy for significantly improving the health of the U.S. 
through 300 specific health objectives spanning areas such as maternal and child health, 
cancer, sexually transmitted infections (STIs), and vaccines.1 The legacy of “Healthy 
People” has continued through the decades, with increasing emphasis on prevention, and 
expansion of disparity groups. Attention has increasingly focused on preventable cancers, 
such as cervical cancer caused mainly by human papillomavirus (HPV).5  
High priority research to advance prevention of HPV-associated cancers includes 
effective communications about HPV and the safe and effective HPV vaccines to 
accelerate uptake, and development of cost-effective research to do so efficiently in at-
risk populations. Barriers to HPV vaccination include lack of knowledge, missed clinical 
opportunities to vaccinate, limited access to healthcare, and cost concerns.5 Effective 
interventions often employ a specific theoretical model, evidence-based information, 
rigorous outcome evaluation, and multidimensional measurement (e.g. knowledge and 
attitudes). Brief, simple educational interventions modeled after early HIV prevention 
efforts have been shown to improve knowledge of HPV and HPV vaccination.4  
Purpose of the Study 
The purpose of this study was to (1) assess the efficacy of a brief educational 
intervention in improving HPV-related awareness, knowledge, and attitudes and (2) 
determine if impact varies by gender, ethnicity, and sexual orientation in a purposive 
sample of ethnically and sexually diverse 18-26-year-old Florida International University 
(FIU) college students. The intervention group was composed of students registered in 
the course WST 3641- “LGBT and Beyond: Non-Normative Sexualities in Global 
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Perspective,” a course in which LGBTQ undergraduate students are known to be 
overrepresented (~35% LGBTQ students). 
Theoretical Foundations 
To explain how gender, ethnicity, and sexual orientation are associated with 
levels of knowledge and attitudes towards HPV, the Health Belief Model (HBM) in 
conjunction with the Transtheoretical Model (TTM) guided the study design, intervention 
content, and interpretation of results. 
Figure 1.1. Model of Theoretical Foundations  
 
  
 HBM posits that beliefs and attitudes about a specific disease influence decisions 
about prevention, particularly vaccination behavior.6 HBM has been successfully 
 4 
 
validated and used to guide many public health interventions aimed at behavior change 
among various populations, and develop effective health messages within and without an 
intervention framework.7 
This study utilized the HBM constructs of perceived susceptibility, threat, 
severity, cues to action, as well as perceived barriers and benefits framed within the brief 
educational presentation aimed at preventing HPV infection and encouraging vaccination. 
Constructs informed the manner of information presentation, and how to measure uptake 
of the information by participants. Knowledge, the largest barrier related to HPV-related 
behaviors, is an integral construct of this theoretical model, being a prerequisite for 
making informed decisions about behavior change and vaccination.8 
This study also utilized TTM, a theory that integrates several constructs of 
behavior change to assess or even predict readiness to engage in a new or healthier 
behavior.9,10 Rather than a single decision-making event, TTM considers behavior change 
as a process in which individuals progress through a series of stages (precontemplation, 
contemplation, preparation, action, and maintenance) depending on their baseline 
readiness to adopt or perform a health behavior. These constructs of TTM were used to 
determine participants’ stage of change and associations related to each stage, and were 
measured at baseline, prior to intervention exposure.  
Study Setting: WST 3641 LGBT and Beyond: Non-Normative Sexualities in 
Global Perspective 
WST 3641 is a 3-credit course at Florida International University designed to 
introduce students to the study of global non-normative sexualities and genders. 
According to the course syllabus,11 students gain an interdisciplinary understanding of 
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gender studies with historical, sociological, and geographical, underpinnings. Through 
this course, students explore concepts related to lesbian, gay, bisexual and transgender 
(LGBTQ)-identified individuals as well as those whose sexual and gender identities, 
practices, and experiences fall outside such designation. In this sense, students learn to 
understand how and when classifications, assumptions, concepts, and theories of 
sexuality and gender prove inappropriate for other cultural contexts. Students examined 
how modern non-normative sexualities and genders around the world exist at the 
intersection of local and global processes. 
Research Aims and Hypotheses 
Three research questions were based on student knowledge and attitudes 
regarding HPV and related topics, which were operationalized based on students’ survey 
results, with intervention acceptability and efficacy determined quantitatively through a 
post-intervention survey. 
Research Question 1. In a sexually diverse sample of undergraduate students 
what is the difference in knowledge about HPV and the HPV vaccines among students of 
varying genders, ethnicities, and sexual orientations before and after implementation of a 
brief educational intervention? 
Research Question 2. How can HPV-related attitudes be characterized among 
samples of undergraduate students of varying genders, ethnicities, and sexual orientations 
before and after implementation of a brief intervention? 
Research Question 3. How acceptable and efficacious is a brief educational 
intervention in a university classroom setting to educate sexually diverse undergraduate 
students about HPV and HPV vaccination? 
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To answer these research questions, the following aims were developed, and the 
associated hypotheses were tested. Chapters IV, V, and VI, each address one of these 
aims. 
Aim 1 (Chapter IV). To assess baseline differences in HPV-related awareness, 
knowledge, and attitudes between genders. 
H0: There are no differences between genders in baseline awareness, 
knowledge, or attitudes in HPV-related topics. 
H1: At baseline, there are statistically significant differences between men and 
women in HPV-related awareness, knowledge, and attitudes. 
Aim 2 (Chapter V). To evaluate the efficacy of a brief intervention in improving 
HPV-related awareness, knowledge, and attitudes among ethnically diverse college 
students. 
H0: There are no differences in intervention outcomes between Hispanic and 
non-Hispanic participants. 
H1: There are statistically significant differences in intervention outcomes 
between Hispanic and non-Hispanic participants. 
Aim 3 (Chapter VI). To evaluate the efficacy of a brief intervention in improving 
HPV-related awareness, knowledge, and attitudes among sexually diverse college 
students. 
H0: There are no differences in intervention outcomes between LGBTQ and 
heterosexually-identifying participants. 
H1: There are statistically significant differences in intervention outcomes 
between LGBTQ and heterosexually-identifying participants. 
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Delimitations 
Study participation was restricted to students at least 18 years old attending FIU.  
Students attending college create a unique chance to access individuals who may have 
missed opportunities to become vaccinated against HPV as minors, and are now of age to 
make vaccination decisions of their own volition. Students chosen for this study included 
those registered for the FIU courses WST 3641- “LGBT and Beyond: Non-Normative 
sexualities in Global Perspective”, which allowed for a sample with a diverse blend of 
ethnicities and sexual orientations, and IDS 3189: “International Nutrition, Public Health 
and Economic Development”, which served as a comparison group. 
Limitations 
Since this study was performed in the unique urban setting of Miami-Dade 
County, the results of this research may not be applicable to those attending other 
universities, and living in other geographical areas. Non-probability purposive sampling 
was used to include diverse sexual orientations; participants were not representative of all 
students at Florida International University, or the south Florida area. Collection of self-
reported data limited the ability for these data to be independently verified for bias. 
Recall and social desirability biases may also have affected the responses of study 
participants. 
Assumptions 
The underlying assumptions of this research are that the participants responded to 
survey instruments accurately and truthfully, and that they had at least an 8th grade 
English reading and comprehension level. Survey instruments were valid and reliable 
based upon literature reviews and pilot testing.  
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Importance of Study 
Students attending college create a unique opportunity to access individuals who 
may have missed opportunities to become vaccinated against HPV, and are now of age to 
make vaccination decisions of their own. The south Florida region has particularly high 
rates of infection, and low rates of vaccination.12 Ethnic minorities and LGBTQ 
individuals are less likely to receive relevant vaccination recommendations from 
healthcare providers, in addition to perceiving a lower threat of HPV.  
To increase HPV vaccination uptake and close gaps in knowledge and health 
behaviors among sexual and ethnic minority groups, knowledge and attitudes related to 
HPV and HPV vaccination should be examined and addressed.  The results of this study 
will guide future interventions and policy to create culturally appropriate messages in 
settings that maximize opportunities for change. This study also represents an opportunity 
to contribute to multiple Healthy People 2020 goals related to LGBTQ health, and 
vaccine uptake.13 
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CHAPTER II 
 
Review of the Literature 
Human papillomavirus (HPV) infection is the most common STI globally.1 High-
risk subtypes of the virus are human carcinogens, responsible for cervical, genital, anal, 
and oropharyngeal cancers. Low-risk subtypes are the cause of genital warts. Almost 80 
million sexually active adults, one in four in the United States, are infected with HPV, 
despite the preventable nature of the infection.1 Young adults age 15-24 account for 
approximately half of all new infections every year.1,2 An estimated additional 14 million 
will become newly infected each year if action is not taken to provide optimal prevention 
options to those at highest risk.  
Causation and Risk 
In 1983, HPV was characterized as the biological factor causing cervical cancer, 
genital warts, and even penile cancer by a team of researchers led by Harald zur 
Hausen.3,4 Primary research was aimed at determining the DNA sequences of the various 
isolated strains of the virus for detection, determining that HPV-16 and -18 are the most 
virulent strains, causing the majority of pre-cancerous cervical dysplasia and cervical 
cancer itself. Zur Hausen was awarded the Nobel Prize for Medicine or Physiology in 
2008; soon after discovery, this claim was confirmed in other laboratories.5 
Once the cause of cervical cancer provided verification that it was indeed sexually 
transmitted, researchers began to explore the various risk factors and exposures which 
increase the chances of contracting the disease. As early as 1990, Moscicki et al. studied 
sexually active female adolescents, finding those with an active HPV infection had 
significantly more lifetime sexual partners than their uninfected counterparts, likely a 
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result of exposure to multiple sources of infection.6 The authors note that the majority of 
the participants who tested positive for oncogenic HPV strains had normal Papanicolaou 
(Pap) test results, indicating the need for early preventative and detection measures prior 
to allowing the disease to advance. It has been suggested that the majority of the HPV 
infections among younger females are due to exposure through a new partner, and may 
be a more short-lived, transient infection.7 A study in Denmark shares these sentiments, 
adding that these transient infections are more often associated with the low-risk, non-
oncogenic HPV types.8 
A few studies indicate that among older women, persistent and/or latent HPV 
infections are more common, possibly leading to higher risk for cervical cancer 
outcomes.8,9 Munoz et al. (1996) found that among middle-aged women in their 40s and 
50s, having six or more lifetime sexual partners was associated with a fourfold increase 
in risk.10 In addition, there was a statistically significant positive association between 
HPV infection and low socioeconomic status as well as previous C. trachomatis 
(chlamydia) infection. Munoz et al. also found that infections were found among women 
who were not recently sexually active, in accordance with previous findings that indicate 
that HPV infections could be persistent in nature, creating a clinically significant 
outcome long after acquisition. 
Sexual behavior and characteristics of male sexual partners have been explored 
among women in college (reported by the woman), and among married men. Burk et al. 
(1996) found that age >20 years, Black or Hispanic ethnicity, currently not attending 
college, and increased number of sexual partners among male partners was associated 
with HPV positivity among the female partners.11 Related studies among Spanish-
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speaking populations confirmed that husbands of women diagnosed with cervical cancer 
are indeed vectors of the HPV virus, and exposure to the virus is mediated by factors 
such as extramarital sexual relationships and a large number of sexual partners.10 
HPV and HPV Vaccination 
More than twenty years after the isolation of HV-16 and HPV-18, vaccinations 
became licensed in the U.S. Safe and effective vaccines have been licensed to protect 
against HPV since 2006, and have been proven to decrease HPV-related morbidity.12 The 
quadrivalent HPV vaccine protects against the two main high-risk and the two main low-
risk HPV subtypes. The 9-valent HPV vaccine protects against these and an additional 
five subtypes.12 The suggested age to routinely vaccinate is 8-11 years old, but the 
recommendation is extended for women up to age 26 and men up to age 21 if they were 
not vaccinated when younger. It is ideal for adolescents to be vaccinated prior to first 
sexual contact. Those with compromised immune systems as well as gay or bisexual men 
are also urged to receive the vaccination though age 26.13 
Both vaccines operate on the same dosage and administration schedule. Each dose 
consists of 0.5mL of virus-like particles (not live virus), which is injected intramuscularly 
in two doses if given between 8-11 years old, three doses otherwise. The second dose is 
administered between 4 and 8 weeks after the first, and the third is administered 12 weeks 
after the second. Women who experience abnormal Pap test results are still encouraged to 
become vaccinated to protect against infection by other HPV types.13  
The U.S. Department of Health and Human Services calculates that 
approximately 53,000 cases of cervical cancer can be prevented if 80% HPV vaccination 
coverage can be achieved among eligible adolescents and young adults who remain a 
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priority population due to disproportionately high HPV incidence.14 The available HPV 
vaccines are currently underutilized in the adolescent and young adult population for 
which they are intended, generating a setting for preventable HPV-associated 
malignancies and related mortality to rise.15 Despite advancements in screening, the state 
of Florida has one of the highest cervical cancer incidence rates nationwide.16 
The efficacy and safety of the vaccines has prompted countries other than the U.S. 
to begin routine vaccination of their adolescents and young adults, with positive results. 
In 2008, Scotland commenced a nation-wide HPV vaccination program in which all 
adolescent females between 12 and 18 years of age were recommended to become 
routinely vaccinated.17 Since 2008, the percentage of fully vaccinated girls has increased 
to over 90% annually in the 12-13 year old cohorts, effectively reducing the prevalence 
of HPV-16 and -18 from 29.8% to 13.6%.18 Additionally, there was a significant finding 
that the bivalent vaccination also provided cross-protection against emerging HPV types 
found to cause cervical cancer.  
Australia, which implemented school-based delivery of the quadrivalent HPV 
vaccine to 12-13 year old girls in 2007, decided in 2010 to extend the use of the vaccine 
to boys and men up to age 26.19 Recognizing the risk that HPV poses to men who have 
sex with men (MSM) in addition to the benefits to women from men receiving the 
vaccine, Australian health officials have found that extending the vaccine to adolescent 
and young men is not only cost-effective, but necessary to reduce the burden of HPV-
related disease. Georgousakis et al. (2012) indicate that practices in Australia can serve as 
an example of how other countries can implement an immunization program which 
maximizes coverage and is cost-effective.19  
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The burden of HPV-related disease in the U.S. exacerbates rising healthcare costs 
despite undeniable evidence the vaccines can reduce HPV incidence.20 In the absence of a 
national vaccination program similar to those proven successful in other high-income 
countries,21 coverage rates are marginal in the U.S., primarily due to safety concerns and 
controversy.2,16 In 2014, all three doses of the HPV vaccine were completed by 40% of 
adolescent girls and 22% of boys in the U.S.,16 falling far below the objective of 80% as 
outlined in Healthy People 2020.22 Despite a modest increase in vaccination since 2012 
(particularly in young men), HPV vaccine coverage in the U.S. remains considerably 
lower than other routine adolescent vaccines.16 Prelicensing studies specified that the 
implementation of vaccination of males would be acceptable, though parents were still 
more comfortable with vaccinating girls rather than boys for HPV.23 
A systematic review conducted by Kessels et al. (2012) found that vaccine uptake 
until 2011 (excluding males) was largely based on structural barriers such as having 
health insurance, having a healthcare provider, and utilization of healthcare.24 In addition, 
the authors discovered that positive vaccine attitudes and higher vaccine knowledge also 
played a major role in the uptake of the vaccine among teenaged girls as well as intention 
to vaccinate. Negative predictors among parents of vaccine uptake were found to be 
concerns regarding the safety of the vaccine, and possible negative side effects. Several 
studies on parental acceptance of the HPV vaccine indicated that many parents felt that 
vaccinating their child may lead to early initiation of sexual activity and even 
promiscuity, prompting parents to delay vaccination of their child until they were 
older.25–27 Despite widespread concerns related to sexuality and the HPV vaccine among 
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parents across the world, multiple studies have indicated that receiving the vaccine has no 
effect on sexual debut or increase of risky sexual behavior at any age.28,29 
College Students’ Knowledge of HPV 
An early study found that of various STIs assessed, college students knew the 
least about HPV, with 37% of students never even hearing of the virus.30 Among female 
students who reported being diagnosed with HPV, 68% had not heard of the virus before 
being diagnosed.  Men were less knowledgeable about HPV, despite their high 
prevalence of HPV infection.   
HPV knowledge deficits among college students have not been resolved: a 2012 
survey of college males aged 18-25 found that 74% of the participants had not received 
the HPV vaccination, and only 14.2% had completed the full series.31 This study also 
found similar results as previous studies regarding knowledge of the virus and vaccine: 
almost 50% of the respondents had never heard of HPV, nor were they aware that there 
was a vaccine. Furthermore, many of the young men did not perceive risk for contracting 
the virus.  Participants also had low awareness that men should be vaccinated against 
HPV, and low awareness that they fell within the age bracket recommended for 
vaccination. These perceptions were common despite reporting low condom use and high 
numbers of lifetime sexual partners. Compounded by the gender disparities in vaccination 
uptake, knowledge deficits about HPV and HPV vaccine exist for ethnic and sexual 
minorities, contributing to an increased risk in minority populations.32 
Hispanic Attitudes toward HPV 
 Hispanics or Latinos are the largest, and fastest-growing minority population in 
the U.S.33 They share a common language and culture, with attitudes and values that tend 
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to differ from those of non-Hispanics. Hispanics are generally grouped as a single ethnic 
category (independent of self-identified race), although they represent multiple 
nationalities and are culturally heterogeneous.33 
In the U.S., Hispanic women suffer from the highest cervical cancer incidence 
rates, and Hispanic men have a higher incidence of HPV-associated penile cancer than 
non-Hispanic men.34 These disparities prompted health agencies to prioritize Hispanics 
for cervical cancer screening, STI prevention, and educational interventions.35 Hispanics 
are less likely to have heard of HPV or HPV vaccination than non-Hispanic whites.36 
HPV-related knowledge has been examined as a determinant of HPV vaccine 
acceptability and uptake; however, distinctions between Hispanics of different 
demographic backgrounds are not often made.37,38 Immediately following the 
recommendation for HPV vaccination, Hispanic rates of HPV vaccination uptake were 
lower than non-Hispanic whites,39 although vaccine initiation is now higher among 
Hispanics.40 Despite this, Hispanic parents are more likely to be concerned about vaccine 
safety than non-Hispanic whites,38 yet are also more likely to follow a healthcare 
provider’s recommendations and less likely to refuse a vaccine when recommended.41  
The majority of studies assessing HPV-related topics among men focused on 
immunocompromised men or MSM, and rarely examined Hispanic men.42–44 Heritage 
and culture may play a large role in the healthcare decisions of Hispanic men, especially 
in health-seeking behaviors such as vaccination.45 Beyond ethnic identity, the socially 
constructed composite defining Hispanic masculinity and other gender norms may also 
influence HPV knowledge and vaccination behaviors.46 Machismo has a role in framing 
the views that health enables manhood, and the identity of manhood dictates health-
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seeking behaviors.45 Among 113 Hispanic college men surveyed in southeastern U.S., 
only 30% agreed that men were at risk for contracting HPV, and only 12% felt personally 
threatened by that risk.45 Less than half intended on becoming vaccinated against HPV.  
LGBTQ and HPV 
Healthy People 2020 indicates that “improving health of LGBTQ is a public 
health priority”.22 Whereas several studies describe the lack of knowledge and poor 
perceptions of HPV risk among college students,47–50 limited data are currently available 
about HPV knowledge and attitudes among LGBTQ university students. Despite having 
similar prevalence as heterosexuals, many LGBTQ persons are less knowledgeable about 
HPV, perceiving they are less susceptible to HPV and its effects due to sex behavior 
differences.51 
MSM have specific risks for anogenital warts and associated cancers, making this 
often-overlooked group especially needy of the HPV vaccine, despite having consistently 
low knowledge of HPV, similar to heterosexual males.52 Although LGBTQ are cited as a 
public health priority, only 4.9% of MSM reported receiving any number of doses of 
HPV vaccine as reported in the National HIV Behavioral Surveillance System in 2011.53 
Approximately 75.9% of the sample had visited a healthcare provider within the previous 
year.51 A 2012 meta-analysis found anal HPV infection to be very common in MSM 
(63.9%), especially in immunocompromised individuals (92.6%), many exhibiting signs 
of anal cancer.54 
Up to 30% of women who have sex with women (WSW) have a current HPV 
infection, with up to 25% of WSW reporting diagnoses of cervical abnormalities, a rate 
that is similar to heterosexual women.55 Despite the similarities between WSW and 
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heterosexual women in this respect, many sexual minority women perceive that they are 
less susceptible to HPV and its effects given the nature of their sexual activities. A recent 
study found that from 2009-2012, WSW received the HPV vaccine at similar rates as 
heterosexual women, although predictors of vaccine uptake were different for the two 
groups.56 
With so many studies consistently describing the lack of knowledge of HPV and 
HPV vaccine among young women, and even more so among young men, 
recommendations have been made that educational interventions be targeted at the young 
adult population.52 The college and university setting create an optimal environment for 
education about the virus and uptake of the vaccine, and possibly removing structural 
barriers which prevent vaccination among those who are knowledgeable about the 
vaccine. There is a need for HPV research with more diverse samples of men, especially 
in southern states, a region which experiences some of the lowest HPV vaccination rates 
in the country as well as some of the highest HPV infection incidence rates.57 Many 
studies30,58 concurrently indicate the need for implementing HPV educational and vaccine 
promotion programs, as well as continued focus on the importance of male HPV 
vaccination.59 
It has been over ten years since the bivalent and quadrivalent HPV vaccines were 
recommended in the U.S. With the recent licensure of an improved 9-valent HPV vaccine 
in December 2014, increased global media attention has been paid to HPV related issues 
of vaccine uptake and attitudes. 60,61 Barriers such as lack of knowledge and unsupportive 
attitudes must be characterized to close the gap of vaccination uptake and health 
disparities among genders, ethnicities, and sexual identities and orientations.15 The 
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proposed project represents a timely assessment of the progress that has been made in 
increasing awareness and improving attitudes of this underutilized vaccine. 
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CHAPTER III 
Methodology 
Sample 
 Institutional Review Board approval was obtained from Florida International 
University’s Office of Research Integrity and granted through April 2017 for 
implementation of the intervention and collection of survey data from approximately 400 
participants enrolled in the FIU Women’s Studies course WST 3641: “LGBT and 
Beyond: Non-Normative Sexualities in Global Perspective” (Appendix A). This IRB 
protocol was amended in November 2016 to reflect the addition of data collection in the 
course IDS 3189: “International Nutrition, Public Health and Economic Development” in 
the semesters of fall 2016 and spring 2017 as a control group for the intervention. Survey 
data were collected once per semester per course until spring 2017, with the exception of 
fall 2015. The intervention group was a purposive sample; the womens’ studies course 
was selected for this study due to the historical overrepresentation of LGBTQ students 
enrolled. Students 18 years of age or older were eligible to participate in the study.  Any 
students who did not meet the age requirement were allowed to participate in educational 
activities, but did not take part in survey data collection. Based upon a power analysis, a 
sample size of 317 should have produced 80% power at the .05 level of significance to 
detect expected effects based on a review of relevant literature. Enrollment of WST 3641 
was between 65 and 90 students per semester. 
Questionnaires 
Pre- and post-tests, which were self-administered written surveys, were adapted 
from the North Carolina Men’s Health Survey1,2 and developed by a team of graduate 
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public health students in the spring semester of 2015 in the course PHC 6750: “Program 
Implementation and Evaluation” (Appendix B). The pre-/post-test surveys were pretested 
with a focus group of 16 graduate public health students. Each survey took approximately 
five minutes to complete.  
 Demographic data were collected about the participants (age, gender identity, 
ethnicity/race, health insurance status, relationship status, sexual practices), followed by 
questions regarding current HPV vaccination status and willingness to receive the 
vaccines. True/False questions were used to measure knowledge about HPV and the HPV 
vaccine, and a five-point Likert scale was used to rate questions regarding attitudes 
toward severity, susceptibility, and acceptability related to HPV and the available HPV 
vaccines. 
Data Collection 
 At the beginning of the designated class, students were read a brief statement 
regarding voluntary participation and consent, then administered the pre-test survey. 
After collection of the completed surveys, the students participated in an educational 
intervention, which consisted of dissemination of HPV and HPV vaccination information 
through a 30-minute PowerPoint presentation followed by a 10-15-minute question and 
answer session. Post-intervention data were collected through the administration of the 
post-test, which measured the same components as the pre-test, in addition to an 
evaluation of the components of the intervention.  
Data Analysis 
 The means, standard deviations, and other descriptive statistics were calculated 
and subsequently analyzed by gender, sexual identity, and race/ethnicity to determine 
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homogeneity between data collection points (semesters) and explore differences among 
these groups. Some survey questions were reverse-scored so results can be analyzed with 
all responses in the same direction. Wilcoxon-Rank Sum and repeated measures ANOVA 
were performed on matched-pair (pre- and post-test) Likert questions to determine if 
these differences were statistically significant. Binomial tests were performed to 
determine post-intervention outcomes for students who specified “don’t know” on 
baseline knowledge items. Analysis of covariance (ANCOVA) was used to determine 
whether the post-intervention knowledge means, adjusted for pre-test scores, differed by 
gender.3 Repeated measures ANOVA were also used to assess if the intervention 
influenced mean change in knowledge scores from pre to post differed by independent 
variables. Pearson’s Chi-Square test or Fisher’s Exact test was performed to determine 
differences in between and among groups and categorical variables, and Cochrane-
Mantel-Haenszel tests characterized individual pre- versus post-intervention categorical 
measures stratified by certain demographic characteristics. Statistical significance was set 
at P<0.05. All analyses were performed using SPSS 20.0.5 
Pilot Testing  
  Intervention planning and implementation are iterative processes. Each time the 
intervention was carried out is a learning experience for not only the participants, but the 
researchers as well. Process evaluations of the pilot intervention conducted in April 2015 
prompted enhancements for the presentation component of the intervention, as well as the 
surveys. 
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Summary of Pilot Findings 
Selected intervention evaluation results of the pilot study were presented the 30th 
International Papillomavirus Conference in September 2015.4 LGBTQ students (n=38) 
were similar to heterosexual students (n=43) regarding demographic characteristics and 
lifetime sexual experiences (Table 1.1).  
 
Table 3.1 Differences Between LGBT and Heterosexual Students 
 
LGBTQ students found the question and answer session more useful and rated the 
overall session “very positive” (P<0.10) (Table 1.2). 
  
Table 3.2 Student Responses Regarding a Brief HPV Educational Intervention 
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All participants regarded the session helpful in formulating a decision about 
vaccine uptake (Table 3). Thirty-five percent expressed strong intentions to be vaccinated 
after the classroom intervention (P=.04). 
 
Table 3. Intervention Results by Student Sexuality 
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CHAPTER IV 
 
Are Men Being Left Behind (Or Catching Up)? Gender Differences in HPV-Related 
Awareness, Knowledge, and Attitudes Among Diverse College Students 
Abstract 
 
Objective: We assessed awareness, knowledge, and attitudes about human 
papillomavirus (HPV). Participants: From April 2015 to February 2017, 386 
undergraduates were recruited in a South Florida university. Methods: A survey of HPV-
related awareness, knowledge, and attitudes was designed and conducted. Results: Most 
(84%) had heard of HPV, and 70% had favorable attitudes toward vaccination. Only 28% 
of men and 55% of women had received ≥1 dose vaccine, 4% reported receiving three 
doses. Those with 1 dose were more knowledgeable about HPV (P=0.01).  High 
knowledge scores were recorded for 30% of respondents, and strongly associated with 
perceived knowledge (P<0.001). Negative attitudes toward HPV vaccine acceptance 
were associated with low knowledge scores and undervaccination. Conclusions: HPV 
knowledge and vaccine uptake remain problematic among college students, and both are 
associated with negative HPV vaccine attitudes. HPV educational efforts should target 
young men as HPV-related cancer morbidity continues to rise in men. 
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Introduction 
 
Human papillomavirus (HPV) infection is the most common sexually transmitted 
infection (STI) in the world.1 Although most HPV-infected persons clear the virus 
completely, HPV causes multiple adverse clinical outcomes in both men and women. 
Due to the long-established connection between some HPV subtypes and cervical cancer, 
women were initially thought to be the only population burdened by the virus’ clinical 
outcomes,2,3 resulting in treatment and prevention solutions solely targeting women.4–6 
Several studies estimate that HPV incidence and prevalence in men are similar to 
women’s, although substantial variability may exist by location and population.7 This 
evidence has shown HPV to be the cause of over 90% of genital warts in men, who 
experience a longer duration of this outcome than women, and incur more treatment 
costs. HPV is also responsible for the majority of male anal, oropharyngeal, and penile 
cancers,8,9 creating substantial health and economic burden beyond that of cervical 
cancer. The direct medical costs of HPV-related outcomes in the U.S. were estimated to 
be $1.7B in 2008.10 HPV-related cases of oropharyngeal cancers in otherwise healthy 
men will soon surpass the number of cervical cancer cases in the U.S.11 Despite this 
trend, men’s knowledge and attitudes toward HPV have continued to lag behind 
women’s, a seemingly continuous effect of previous female-focused prevention efforts. 
The Advisory Committee on Immunization Practices has recommended safe and 
effective HPV vaccination for 9-26 year old girls and women since 2006.12 Substantial 
decreases in vaccine-preventable HPV subtype infections were evident after only the 
sixth year of vaccine implementation in the U.S.; a 64% decrease was observed among 
those 14-19 years and a 34% decrease among those 20-24 years.13 The quadrivalent HPV 
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vaccine was additionally recommended for boys and young men in 2011.12 Despite its 
proven success, HPV vaccination rates among boys and men in the U.S. are far below the 
recommended Healthy People 2020 target of 80% coverage easily achieved for other 
routine vaccines.14  
For college students, HPV infection constitutes a substantial threat considering 
this population’s increased sexual activity and sexual risk-taking.15–17 College-aged 
young adults (20-24 years old) have the highest prevalence of anogenital HPV 
infection.8,13 Most universities provide onsite medical facilities for students, offering 
HPV vaccination and education among other preventive services.18 Despite the 
availability of these services, HPV-related knowledge in college students may be low 
compared to other STIs, especially among young men.19 The sluggishly growing HPV 
vaccination rates leave a large population of college-aged young adults unprotected, 
despite eligibility to receive catchup doses.20 Several studies report that vaccine 
acceptability is correlated with awareness and knowledge about HPV,21–24 yet until 
recently, little research has included college-aged men’s attitudes toward HPV 
vaccination.25–27  
Research focused on characterizing disparities in awareness and knowledge is 
especially needed in ethnically diverse areas such as the state of Florida, which has some 
of the lowest HPV vaccination rates in the country, as well as some of the highest 
cervical cancer rates.28 Evaluating what men and women in college know, think, and do 
about the threat of HPV can offer possible solutions to remedy the underutilization of the 
HPV vaccine in a population at high risk for contracting this preventable infection. This 
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report explores differences in HPV-related awareness, knowledge, attitudes, and practices 
among college students in south Florida. 
Methods 
A cross-sectional study of university students focusing on students’ HPV-related 
awareness and knowledge, as well as attitudes and uptake of HPV vaccination, was 
conducted from March 2015- February 2017. The university’s institutional review board 
granted exempt approval status prior to study implementation. 
Participants 
Men and women registered in four sections (semesters) of an undergraduate 
gender studies course taught by the same instructor from March 2015- February 2017 
were recruited for this study. Additionally, students enrolled in undergraduate public 
health and dietetics courses in January and February of 2017 were recruited. Students 
aged 18 or older who were present on the day of data collection were invited to 
participate by completing a questionnaire. Participants were read a brief statement 
regarding voluntary participation and consent. Students were not required to answer 
every item or return the questionnaire to the study team. 
Students were included in the current study if they were (a) 18 years or older at 
the time of data collection, (b) registered for the college course in which data collection 
took place, and (c) were present in class at commencement of data collection.  
Survey Procedures 
At the time of data collection, the research team explained the purpose of their 
visit to the class and presented the statement of informed consent. Participants under the 
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age of 18 years were identified and excluded from participation, but were welcome to 
remain in the classroom. Written, self-administered questionnaires were then distributed 
to eligible participants. The survey took approximately 5-10 minutes to complete. Upon 
completion surveys were deposited by each student into a large envelope or box carried 
by circulating research team members.  Participants received tokens of appreciation for 
their time, such as promotional pens, pencils, lip balm, and condoms.  
Measures 
The questionnaire consisted of 34 items. Nine were sociodemographic or 
descriptive items.  Eighteen items were adapted from the 100-item 2009 University of 
North Carolina Men’s Health Survey.25,29 The remaining items were developed in March 
2015 after a review of the literature and were based on the aims of the current study. 
Questionnaires were pretested with a focus group of 16 graduate public health students 
and revised based on feedback received (questionnaire is available from authors upon 
request).  
Sociodemographic and baseline data (i.e. age, gender identity, ethnicity/race, 
health insurance status, sexual orientation, relationship status, sexual activities, and 
number of partners) were self-reported. Awareness of HPV was assessed with a single 
question that asked participants, “Have you heard of HPV or human papillomavirus 
before today?” (yes, no, don’t know). Participants then indicated how many doses of 
HPV vaccine they had received as of that day (0, 1, 2, 3, don’t know), and subsequently if 
they were not already fully vaccinated, if they were willing to take the HPV vaccine (yes, 
no, don’t know). Participants also responded to the question, “Before today, I have never 
thought of getting the HPV vaccine for myself” (yes, no, don’t know). 
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Eleven questions measured beliefs about various HPV-related statements on a 
five-point Likert scale ranging from “strongly agree” to “strongly disagree” with an 
additional “don’t know” option. We developed an ad-hoc scale consisting of the five 
Likert items specifically addressing vaccination. We found the Carolina HPV 
Immunization Attitudes and Beliefs Scale by McRee et al.30 for caregivers and adapted 
by Dempsey et al.31 for young women to be well suited for our investigation, but too 
lengthy for inclusion in our brief questionnaire. Our scale succinctly gauged participants’ 
attitudes toward the HPV vaccine, who are appropriate recipients, and vaccines in general 
(e.g., “Vaccines in general are safe and effective,” “My opinion of the HPV vaccine is 
mostly positive”). Items were coded such that “strongly agree” or “agree” corresponded 
to a positive attitude toward that topic. Reliability assessment of the vaccine attitudes 
scale was conducted with Cronbach’s alpha (n=397, α=0.91). 
Participants were then asked to describe their perceived level of knowledge of 
HPV and the vaccine in two separate questions as “Nothing at all,” “a little,” “a moderate 
amount,” or “quite a lot”. Aside from respondents’ reported self-perceived knowledge 
related to HPV, we measured knowledge with seven true/false items. We created a 
composite knowledge score by summing the number of correct responses (maximum of 
seven total). Respondents’ knowledge was categorized as either high (four or more 
questions correct) or low (three or less questions correct). Knowledge items included 
questions such as “Some strains of HPV are harmless” (True) and “The HPV virus causes 
herpes in men and women” (False).  Participants were not required to answer each 
question before proceeding to the next. We report percentages for the complete sample, 
and percentages (n/N) when analyses contain missing data. 
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Data Analysis 
Univariate means or percentages were first calculated for sociodemographic 
variables in the entire sample and then by gender. Descriptive statistics were 
subsequently calculated to determine homogeneity between data collection points and 
sites (semesters and courses). When differences were negligible, data were pooled.  
Categories for items regarding awareness of HPV and number of doses categories 
were collapsed into dichotomous outcomes. Likert questions were collapsed into 
“Strongly Agree/Agree”, “Disagree/Strongly Disagree”, and “Neutral/Don’t Know”. 
Likert items were reverse-scored if necessary to allow results to be analyzed together. 
Demographic differences in the knowledge score and HPV attitudes scale were 
determined using Pearson’s chi-square test. 
We then explored correlates of five HPV-related outcomes: awareness, self-perceived 
knowledge, measured knowledge (score), willingness to vaccinate, and vaccine beliefs (scale). 
Sociodemographic characteristics such as age, gender, race, ethnicity, health insurance status, 
HPV awareness, and HPV vaccine uptake were among potential correlates.  
A post-hoc power analysis was conducted with GPower,32 which indicated a sample size 
of 358 was needed to detect effect sizes of w=0.5 for tests of independence. Statistical 
significance was set at P<0.05. All analyses were performed using SPSS 20.0.33  
Results 
Sample Characteristics 
Of the 409 students eligible to participate, 389 (95%) completed the survey and 
were included in the current analysis. Three participants were under the age of 18 and 
were excluded. Participants had a mean age of 22.3 years (SD=4.9) and were mostly 
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female (70%). Approximately two-thirds were Hispanic (66%) and single (66%), and 
over half identified their race as white (59%). Less than two thirds (62%) identified their 
orientation as heterosexual/straight and 55% reported between one and five lifetime 
sexual partners at the time of survey. Men were more likely to report greater than ten 
lifetime sexual partners than women (28% vs. 10%, respectively). Students reported ever 
having more oral (80%) and vaginal (69%) lifetime sexual experience than anal sex 
experience (36%). Fourteen percent reported having no lifetime sexual partners. Over 
three-fourths reported having health insurance coverage (78%; Table 1). 
HPV Awareness and Vaccination Status 
Overall, most participants (84%) had heard of HPV; more women were aware of 
the virus than men (86% versus 77%, respectively), although this difference was not 
significant (P=0.07). Number of lifetime sex partners was not associated with HPV 
awareness; however, participants who reported being single were less likely to be aware 
of HPV than those in a relationship (P=0.01). No significant differences were found by 
race (Black, White, other), insurance status, or age. 
Despite being mostly aware of HPV, the majority (60%) of participants had not 
received any HPV vaccine doses or did not know their vaccination status at the time of 
survey. Participants who had received any doses of HPV vaccine were more likely to 
report having heard of HPV (𝑃 ≤0.001; Table 2). While 40% of respondents had at least 
one dose of HPV vaccine, only 15.3% had received three doses. Significant vaccination 
differences by gender were evident; 72% of men had received no or an unknown number 
of doses of HPV vaccine compared to 55% of women (P=0.01). Only 4% of men in this 
sample had all three doses compared to 26% of women (P≤0.001). Forty-five percent of 
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men and 27% of women said they had never thought about getting the HPV vaccine for 
themselves (an additional 23% of men said they don’t know; P<0.001). 
Perceived and Measured HPV-Related Knowledge 
 In response to the question “How much would you say you know about HPV?” 
(perceived knowledge), 69% of men and 62% of women perceived that they knew 
nothing or little (NS), and even more reported knowing nothing or little about the HPV 
vaccine (72% men and 67% women, NS). Seventy percent of participants scored low (3 
correct out of seven) on the True/False knowledge section. There were no significant 
gender differences in overall mean knowledge score; men earned an average score of 2.1 
out of seven (SD=2.1), and women earned an average of 2.5 (SD=1.9, NS). Despite this, 
men (38%) were more likely than women (24%) to score zero points (P=0.005). Only 
seven participants (1.8%) answered all seven questions correctly (Figures 1 and 2). 
Age group was significantly associated with knowledge score; 82% of 18-20-year 
olds in this sample were categorized as having low knowledge versus 62% of 21-23-year 
olds (P<0.001).  A simple main effects analysis showed that age group was not a 
statistically significant influence on men’s knowledge scores (F(1, 106)=0.13, P=0.72). 
However, age was a significant factor in women’s HPV knowledge score (F(3, 
256)=11.3, P<0.001). Age was further analyzed in women by pairwise comparisons 
using Tukey’s post-hoc test, which showed that women in the 18-20-year-old age group 
had a significantly lower mean knowledge score than the other three age groups, and 
knowledge progressively increased with age group (P<0.001; Figure 3). 
 39 
 
Half or more of respondents incorrectly identified herpes or AIDS as diseases 
caused by HPV (58% and 50%, respectively), with no significant differences by gender. 
Participants who received any doses of HPV vaccine (47%) or had >10 lifetime sexual 
partners (46%) were significantly more likely to score high on the knowledge items than 
others (P≤0.001 and P=0.02, respectively).  
There was a strong relationship between perceived and actual HPV-related 
knowledge. Respondents who characterized their HPV-related knowledge as low (77%) 
earned low knowledge scores (P≤0.001). Only 51% of those with a high score perceived 
themselves to be knowledgeable. Similar to knowledge score and age, there was a 
significant difference in gender.  A simple main effects analysis showed that men’s 
perceived knowledge was not independently associated with men’s knowledge scores 
(F(1, 109)=2.6, P=0.11). However, among women, perceived knowledge was 
significantly associated with HPV knowledge score (F(1, 263)=12.7, P<0.001), with 
women who perceived to know moderate/a lot about HPV performing better in 
knowledge score (M=3.0, SE=0.19) than those who perceived themselves to have 
no/little HPV knowledge (M=2.1, SE=0.15, P<0.001). 
Vaccine Attitudes 
In response to the five-item vaccine attitudes scale, 70% of total participants 
reported positive attitudes toward HPV vaccination, with men and women responding 
similarly. Number of doses of HPV vaccine received was significantly associated with 
vaccine attitudes; an association which differed between men and women (2MH(1)=30.9, 
P<0.001). Vaccinated women were over seven times more likely than unvaccinated 
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women to report positive vaccine attitudes (RR=7.1, CI[3.3-15.5]). This contrasts with 
men, whose vaccination status was not significantly associated with vaccine attitudes 
(RR=2.9, CI[0.9-8.7]). 
Of the participants reporting negative attitudes toward vaccines, 85% had 
received either zero or an unknown number of HPV vaccinations (2=31.8, P<0.00). 
Eighty percent of participants with negative HPV vaccine attitudes scored low (≤3/7) on 
the measured knowledge portion of the questionnaire (2=7.6, P=0.01). Of those not 
vaccinated or undervaccinated (vaccine series initiated but incomplete), 58% were 
willing to receive the HPV vaccine, and 27% did not know if they wanted to be 
vaccinated. Participants who had heard of HPV before the day of the survey were more 
willing to be vaccinated than those who had not heard of the virus before (67% vs 27%; 
2=34.8, P<0.001).   
Comment 
 Vaccinating both men and women against HPV is essential to protect against the 
rising HPV-related cancer rate. We focused on gender differences in HPV awareness, 
HPV vaccine uptake, perceived and actual HPV knowledge, and vaccine attitudes. Men 
in our sample appeared to be catching up to women in awareness and knowledge, though 
women were still ahead in HPV vaccine uptake and vaccination intentions. 
Awareness 
Men and women had high levels of HPV awareness (>80%). In 1999, college 
students were largely oblivious to HPV; only 37% of students at a Florida university had 
ever heard of the virus.34 Although men were less aware than women, we found no 
statistically significant difference in 2015-2017. The gender disparity gap may be closing 
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as overall awareness increases among both men and women, an apparent improvement 
compared with earlier research that showed college women were significantly more 
aware of HPV than college men.28,35–37  
Perceived and Measured Knowledge 
Despite high levels of HPV awareness among undergraduate students in South 
Florida, both men and women reported disconcertingly low levels of perceived and 
measured knowledge on the topic. Poor knowledge scores, especially among the 
youngest participants, who would have the most to benefit from vaccination, confirmed 
their self-perceptions. A staggering 38% of men in our study answered no questions at all 
correctly on HPV knowledge. Our results are consistent with previous studies indicating 
that despite being acutely aware of HPV and HPV vaccination, significant knowledge 
deficits persist regarding how HPV is transmitted, what diseases result from HPV 
infection, as well as how to prevent infection effectively. Of various STDs evaluated in 
the late 1990s and early 2000s, college students knew the least about HPV,34,38 and as in 
our study, they confused HPV outcomes with herpes simplex virus or HIV.39  
The youngest women in our sample received significantly lower scores than 
women in older age groups, similar to findings in previous research on age differences.39 
HPV knowledge disparities by age may be explained by older women having more 
encounters with sexual health education, HPV screening in the medical setting, knowing 
someone who has been diagnosed with an HPV infection or related disease, or 
experiencing infection themselves.39  
After the quadrivalent vaccine was introduced and approved for girls and women 
in 2006, there was intense marketing from the pharmaceutical manufacturers and health 
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agencies, but the manufacturer’s decision to market the vaccine to middle class 
consumers as an “anticancer vaccine” effectively detached cervical cancer from its 
sexually transmitted origins, and gender nonspecificity.40 A campaign that provided little 
HPV information possibly may have increased awareness, but failed to increase scientific 
knowledge.41 Low knowledge combined with high awareness may also reflect a lack of 
comprehensive sexual education during the formative years. For over 20 years, Florida 
public schools have adhered to an abstinence-only or abstinence-based sexual health 
curriculum.42 Despite this mandate, Florida lacks consistent state standards for the sexual 
education that is provided, with many students receiving no sexual health education at all. 
These results highlight the need for comprehensive sexual health education at all ages, 
whether it is received from a health care provider, school-based program, or another 
reliable source.  
Attitudes 
We were interested in exploring attitudes toward HPV vaccination, and how those 
attitudes may be associated with vaccination intentions and behaviors. Over 70% of men 
had not been vaccinated in our study, and only 26% of women and 4% of men had 
received all three doses of HPV vaccine, despite men reporting similar awareness and 
knowledge as women. Participants reported favorable vaccine attitudes (70%), yet 
vaccinated women were seven times more likely to have positive views of vaccination 
than unvaccinated women, a distinction not observed in young men.  
The first vaccines approved in 2006 were initially promoted for girls, creating 
earlier mindfulness of HPV and prevention among them. Previous studies with young 
men have found that acceptability of the HPV vaccine has varied from modest (33%–
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48%) to high (78%).21,23,43,44 In the past, the case has been made for altruistic motivation 
for men to be vaccinated, thereby protecting women through their vaccination.45 
However, the steep rise in HPV-related oropharyngeal cancer morbidity in men and the 
potential protective effect of the HPV vaccine for oropharyngeal infection46,47 suggest an 
urgent need to improve vaccine uptake in men to protect themselves from adverse 
consequences to their health.  
Those with negative attitudes toward HPV vaccination were overwhelmingly 
uninformed about HPV, and were likely to be unvaccinated. The positive correlation 
between a favorable attitude and vaccine uptake may be an effect of attitude-behavior 
consistency. Longitudinal attitude studies have found that positive correlations between 
attitude and behavior strengthen as a function of information available on the topic, as 
well as direct experience with the attitude object.48,49 In our sample, those with positive 
attitudes tended to be more knowledgeable, but were also more likely to have already 
received at least one dose of HPV vaccine. 
Limitations 
Limitations of this study include its cross-sectional nature, which precludes ability 
to infer causation or establish a temporal connection in variables of interest, such as HPV 
knowledge and vaccine uptake. This study used a non-probability sample to maximize 
diversity, thus, generalizability is limited. We collected self-reported data from the 
participants, which may subject our results to social desirability and recall biases.  
Our study was conducted in an urban area of south Florida, a state among those 
with the highest percentages of Hispanic and foreign-born residents.50 Florida 
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(specifically Miami-Dade County) also leads the country in number of Cuban-descent 
residents, who are typically not representative of Hispanics from other countries. 
Despite these limitations, these results provide evidence that a significant number 
of young adults in the U.S. lack accurate knowledge about HPV, the HPV vaccine, and 
the importance of preventing HPV infection. 
Implications and Future Research 
 Our results suggest that educational interventions should be delivered to increase 
knowledge and change attitudes toward HPV and HPV vaccination among college 
students, especially men and freshman women. The college setting provides an optimal 
environment for education about the virus and uptake of the vaccine. Furthermore, 
student health centers can assist in removing structural barriers which prevent vaccination 
among those who are knowledgeable.51,52  
Future research can integrate these findings to fine-tune which populations should 
be targeted, and support research aimed at improving knowledge and attitudes regarding 
HPV among men. Qualitative research can be conducted with at-risk groups, such as 
men, to inform the design and development of tailored interventions. This type of 
research would be useful in determining what messages are suitable for this population, 
as well as who provides messages, where messages are delivered, and which approaches 
should be utilized.27  
To expedite the achievement of state and national vaccination goals, several 
actions can be pursued. Florida and other states can review options for the 
implementation and evaluation of comprehensive sexual education for elementary, 
middle, and high school students. Many studies have reported support for such programs 
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from both teachers and parents.42,53 Because there is not a cure for HPV and other viral 
STIs, primary prevention is essential. Florida and other states may in the future follow the 
lead of states such as Virginia, Rhode Island, and the District of Columbia in requiring 
HPV vaccination for school matriculation along with other routine vaccinations.54  
In 2012, former Florida Senator Thad Altman introduced Senate Bill 146, 
requiring that parents and caregivers of students entering grade six at least be given 
information about HPV, related diseases, and the availability of vaccines to prevent its 
transmission.54 The bill died in the Health Policy Committee. In January 2018, Senate 
Bill 1558 was introduced in Florida by Miami Senator Jose Javier Rodriguez which 
would make it mandatory for 11 and 12-year olds attending public school to become 
vaccinated against HPV.56 The bill died in the Health Policy Committee. 
 If HPV vaccination were also required for college matriculation, dramatic 
reductions in HPV-related outcomes might be seen. For young adults, increased gender-
inclusive, targeted information for college students in clinical settings would reinforce 
health promotion messages. To remove barriers such as cost and access, student health 
centers and clinics could determine mechanisms to offer HPV vaccination to students free 
of charge. Providers could conduct a vaccine eligibility assessment at each visit, 
regardless of gender, and during general non-STD visits also. National vaccine registries 
and reporting systems should be integrated and intuitive for clinicians, which would help 
strengthen vaccine reporting and support vaccine recommendation equality.  
Conclusions 
Carrying the majority of the HPV burden, there is a distinct opportunity for 
preventive measures to be improved among 18-26 year olds across the country. Our 
 46 
 
findings indicate the need for aggressive targeting of young adults for education and 
behavioral intervention, with particular attention on young men. Despite general 
awareness of “HPV” and “HPV vaccine” as hot-button terms, participants in this study 
demonstrated an astonishing lack of detailed knowledge about HPV, which is associated 
with negative vaccine attitudes and uptake. Knowledge among young men seems to be 
slowly improving, yet these deficits place unreasonable burden on women to protect 
against a virus that increasingly affects men. Increased knowledge about young adults’ 
awareness, knowledge, and attitudes toward HPV and HPV vaccination is imperative to 
reach the goal of 80% HPV vaccination coverage to reduce the burden of HPV-related 
disease in the U.S. 
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TABLES 
Table 4.1. Sociodemographic Characteristics of Participants By Gender 
Characteristics  Total                      
N=386 
Female               
n=264 
Male                 
n=110 
 Mean(SD) Mean(SD) Mean(SD) 
Age, y 22.4 (5.0) 22.2 (4.5) 22.6 (5.4) 
Ethnicity n n(%) n(%) 
     Hispanic/Latino 248(64.7) 171 (63.6) 77 (67.5) 
     Not Hispanic/Latino 128(33.4) 95 (35.3) 34 (29.8) 
     Not Sure/Unknown 7(1.8) 3 (1.1) 3 (2.6) 
Race 
   
     White/Caucasian 235(62.5) 164 (62.4) 75 (66.4) 
     Black/African American 81(21.5) 57 (21.7) 25 (22.1) 
     American Indian/Alaska                                                             
Native 
2(0.5) 1 (0.4) 0 (0) 
     Asian/Pacific Islander 14(3.7) 9 (3.4) 5 (4.4) 
     More than one race  27(7.2) 23 (7.6) 3 (2.7) 
     Not Sure/Unknown 17(4.5) 12 (4.6) 5 (4.4) 
Sexual Orientation 
   
     Straight 248(64.9) 184 (68.1) 64 (57.1) 
     LGBTQ 134(35.1) 86 (31.9) 48 (42.9) 
Lifetime Sexual Partners  
   
     0 54(14.1) 38 (14.1) 16 (14) 
     1-5 214(55.8) 166 (61.7) 48 (42.1) 
     6-10 57(14.8) 39 (14.5) 18 (15.8) 
     >10 58(15.1) 26 (9.7) 32 (28.1) 
Health Insurance  
   
     Insured 238(78) 161 (75.9) 77 (82.8) 
     Uninsured 53(17.3) 42 (19.8) 11 (11.8) 
     Don't Know 14(4.6) 9 (4.2) 5 (5.4) 
Relationship status  
   
     Single 254(65.9) 171 (63.1) 83 (72.8) 
     Married 16(4.2) 12 (4.4) 4 (3.5) 
     Divorced/Widowed 4(1.0) 3 (1.1) 1 (0.9) 
     In a Relationship 111(28.8) 85 (31.4) 26 (22.8) 
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Table 4.2. Differences in HPV-Related Awareness, Perceived Knowledge, and Vaccine 
Attitudes by Vaccine Initiation 
 
 
Characteristics  
Total  
0 Doses HPV 
Vaccine 
n(%) 
≥1 Dose HPV 
Vaccine 
n(%) 
 
 
P-value  
Heard of HPV before today 
 
 
     Yes 
    
     Yes 257 143 (77.7) 114 (92.7) 0.001 
     No/Don’t Know 50 41 (22.3) 9 (7.3)  
Perceived knowledge of 
HPV    0.007 
     Nothing/Little 216 140 (76.1) 76 (61.8)  
     Moderate/a Lot 91 44 (23.9) 47 (38.2)  
Perceived knowledge of 
HPV vaccination    <0.001 
     Nothing/Little 238 159 (86.9) 79 (64.2)  
     Moderate/a Lot 68 24 (13.1) 44 (35.8)  
Vaccine attitudes    <0.001 
     Positive 210 105 (57.7) 105 (88.2)  
     Negative 91 77 (42.3) 14 (11.8)  
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FIGURES 
Figure 4.1. Low Versus High Perceived Knowledge of HPV by Measured Knowledge 
Score 
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Figure 4.2. Low Versus High Perceived Knowledge of HPV Vaccination by Measured 
Knowledge Score 
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Figure 4.3. Women’s HPV Knowledge Score, Stratified by Age Group 
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CHAPTER V 
Usefulness of a brief intervention in improving HPV-related knowledge and 
attitudes in ethnically diverse students attending a Hispanic-Serving Institution 
Abstract 
Purpose: To evaluate an intervention designed to improve human papillomavirus (HPV) 
and HPV vaccine awareness, knowledge, and attitudes. Design:  Pre- and post- 
intervention surveys. Setting: An urban Hispanic-Serving south Florida university. 
Subjects: Three hundred eighty-seven diverse college students attending a gender studies 
course. Intervention: Students received a brief educational message designed to improve 
HPV-related knowledge and attitudes. Baseline and followup survey data were collected. 
Measures: Outcome measures included baseline and followup awareness of HPV, 
perceived knowledge of HPV and HPV vaccination, measured knowledge score, and 
vaccine attitudes. Analysis: Chi square, ANCOVA, and Wilcoxon Rank-Sum tests were 
used to evaluate the efficacy of the intervention. Results: Hispanic women (48%) were 
more likely to have initiated HPV vaccination than Hispanic men (27%; P=0.006). At 
baseline, 70% of participants scored <4/7 points in knowledge. Hispanic participants had 
more positive attitudes toward HPV vaccination (62% vs. 44%; P=0.009) and were more 
willing to become vaccinated (66% vs. 46%; P=0.02) than non-Hispanic participants. 
Participants’ HPV knowledge improved by 41% after the intervention, with no difference 
by ethnicity in post-intervention score. Conclusion: The intervention was useful in 
improving HPV-related knowledge and attitudes among diverse college students. Future 
studies should examine barriers to vaccination among ethnic minorities. 
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Purpose 
Human papillomavirus (HPV) infection is the most common sexually transmitted 
infection globally, and is responsible for multiple clinical outcomes, such as genital warts 
and cervical, anal, and oropharyngeal cancers.1 Three safe and effective vaccines have 
been licensed to protect against HPV, and have been proven to significantly decrease 
HPV-related morbidity.2 Recent data have not shown any differences in other routine 
vaccine coverage rates by ethnicity; however, there is evidence that Hispanic parents are 
more likely to be very concerned about vaccine safety than non-Hispanic whites.3 Despite 
this, Hispanic parents are also more likely than non-Hispanic whites to follow a 
healthcare provider’s recommendations and less likely to refuse a vaccine for their 
children.4  
Hispanics make up the largest ethnic minority group in the U.S.  Florida leads the 
country in number of residents of Cuban descent.5  Hispanics residing in the U.S. 
generally have lower rates of cancers compared to non-Hispanic whites, apart from 
cancers caused by an infectious agent, as is the case with cervical cancer and HPV.6 
Hispanic women have high rates of HPV infection and low rates of cervical cancer 
screening, leading to higher incidence of cervical cancer than non-Hispanic white and 
Black populations.7,8 While significant variability in cancer rates exists between 
Hispanics of different countries of origins, it has been shown that unlike other Hispanic 
populations, Cubans living in the U.S. have lower cervical cancer rates that are similar to 
non-Hispanic whites.9 This distinct cancer profile may be due to a higher observed 
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education level in comparison to Hispanics from other countries residing in Florida, and 
to Cuban cervical cancer screening rates similar to the U.S.10  
Despite advancements in screening, the state of Florida has one of the highest 
cervical cancer death rates nationwide.11 Despite HPV being vaccine-preventable, and 
clinical outcomes of infection ranging from stigmatizing to deadly, HPV-related 
knowledge is reportedly low among Hispanic populations compared to non-Hispanic 
whites in the U.S.12,13 
HPV educational interventions have been efficaciously employed in various 
settings, primarily with women and parents.14–17 However, less is known about the 
potential impact of HPV education for ethnically diverse communities on knowledge and 
vaccine attitudes. Recent studies have had mixed results in correlating Hispanic ethnicity 
with HPV vaccine acceptability, and many of these had limited participation of Hispanic 
men.18–20 None of these examined HPV vaccinations as a function of vaccine hesitancy, 
which the World Health Organization defines as a “delay in acceptance or refusal of 
vaccines despite availability of vaccination services”.21 Hispanic and other ethnic 
minority groups should be knowledgeable about the potential risks of HPV and the 
benefits that can accrue by becoming vaccinated against it. Additionally, very little is 
known about HPV-related attitudes among young Hispanic residents of south Florida. In 
support of the Healthy People 2020 goal to reach 80% HPV vaccine coverage, the aim of 
this study was to develop and then test the efficacy of an educational intervention for 
improving HPV-related knowledge and attitudes among ethnically diverse students 
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enrolled in a Hispanic-Serving Institution (HSI) in south Florida, a region known to have 
many Cuban and other Hispanic populations and a high incidence of cervical cancer.  
Methods 
Design 
From April 2015 to February 2017, we conducted a brief in-class intervention in 
English with students enrolled at a public, urban HSI in south Florida. The university 
requires all students to speak, read, write, and understand English when enrolled. The 
intervention utilized a pre-test and post-test to evaluate the efficacy of a 30-minute 
educational presentation and question and answer session designed to improve basic 
knowledge of HPV and HPV vaccination. 
Sample 
The educational intervention was targeted to an ethnically diverse purposive 
sample of students enrolled at a large Hispanic-serving university situated in south 
Florida. We recruited from four undergraduate gender studies courses from the spring 
2015 to spring 2017 semesters. In addition, we sampled from three dietetics and public 
health courses in January and February of 2017. Every member of the seven classes who 
attended on the day of data collection was asked to participate (total enrollment of 409). 
Participants were read a brief statement regarding voluntary participation and consent, 
and students were permitted to leave the room at any point if they did not wish to 
participate. Students under the age of 18 were excluded from study participation. The 
university’s Institutional Review Board approved the study protocol prior to 
implementation. 
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Measures 
The self-administered written questionnaires elicited self-perceived and measured 
knowledge about HPV, as well as attitudes regarding severity, susceptibility, benefits, 
and barriers related to HPV and HPV vaccination. The matched pre- and post-
intervention questionnaires consisted of a total of 62 items (38 in the pretest, 24 in the 
posttest). It was adapted in part from the 2009 University of North Carolina Men’s Health 
Survey,22, 23 with additional questions added after a review of the more recent literature. 
Surveys were pre-tested in a focus group and subsequently revised.  
At baseline, demographic data (i.e. age, gender identity, ethnicity/race, health 
insurance status, sexual orientation, relationship status, sexual practices, and number of 
partners) were collected from participants. This was followed by a single question asking 
participants if they had ever heard of HPV or human papillomavirus before that day (yes, 
no, don’t know). Participants then indicated how many doses of HPV vaccine they had 
received as of that day (0-3, don’t know), and subsequently if they were not already fully 
vaccinated, if they were willing to take the HPV vaccine (yes, no, don’t know). 
Participants were then asked to describe their self-perceived knowledge of HPV and HPV 
vaccines in two separate questions as “Nothing at all,” “a little,” “a moderate amount,” or 
“quite a lot”.   
We measured actual HPV knowledge with seven true/false items; correct scores 
were totaled, and respondents were categorized as either high knowledge (four or more 
questions correct) or low knowledge (three or less questions correct). Eleven questions 
measured attitudes toward various HPV-related statements on a five-point Likert scale 
ranging from “strongly agree” to “strongly disagree” with an additional “don’t know” 
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option. All knowledge items were addressed in the educational portion of the 
intervention, and further clarified if needed during the question and answer session. The 
posttest included followup knowledge and attitude questions identical to the pretest with 
additional questions regarding participants’ experience with the intervention.  
Intervention 
The intervention was designed to improve knowledge and attitudes regarding 
HPV and HPV vaccination. It was piloted in its entirety in April 2015. The intervention 
took from 40-50 minutes to complete and consisted of a pretest, moderated educational 
presentation, question and answer session, and an immediate posttest.  
Pre- and post-questionnaires were distributed before delivery of the intervention, 
matched by identical numerical identifiers. Each survey took approximately 5-10 minutes 
to complete, and was collected immediately upon completion. The evidence-based 
presentation contained 26 PowerPoint slides and introduced general information about 
HPV, including virus subtypes, transmission, clinical outcomes, diagnosis, treatments, 
prognosis, and vaccination/prevention options. Presentation messages were tailored for 
ethnically diverse young adults by incorporating physical Hispanic representation in 
intervention materials.24 This was intended to develop “felt targetedness” among 
participants, an important construct in health marketing that identifies the feeling of being 
the intentional recipient of the health information.25,26 The question and answer sessions 
were approximately ten minutes long, and allowed students to ask more specific, often 
situational questions, although many times the questions were meant to confirm 
information already presented. Students received tokens of appreciation at the end of data 
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collection, such as pens, pencils, lip balm, and condoms sponsored by the university’s 
student health center. 
Analysis 
We report percentages for the complete sample, and percentages (n/N) when 
analyses contain missing data. Univariate frequencies were calculated for demographic 
variables in the entire sample, and then stratified by ethnicity (Hispanic versus non-
Hispanic). Survey questions were collapsed into dichotomous outcomes where 
appropriate. Attitude items were coded such that “strongly agree” or “agree” 
corresponded to a positive attitude toward that topic. Pearson’s Chi-Square or Fisher’s 
exact tests were performed to determine differences between and among Hispanic/Non-
Hispanic groups. Wilcoxon rank-sum tests characterized pre- versus post-intervention 
results. In addition, mean knowledge change from pre-test to post-test was evaluated with 
paired sample t tests and one-way ANCOVA. Statistical significance was set at P<0.05. 
Reliability assessment of the knowledge score was conducted using Cronbach’s alpha. 
All analyses were performed using Statistical Package for the Social Sciences (version 
22.0).  
Results 
Descriptive Analyses 
Of the 409 students consenting to participate, two were under the age of 18 and 
excluded from the study. Three hundred ninety-seven participants submitted post-
intervention surveys (98%), seven of which did not include baseline data and were 
excluded. Of these, 382 reported an ethnic identity and were included in the current 
analysis. Participants were mostly female (71%), with an average age of 22 years 
 64 
 
(SD=5.1). Over half were Hispanic (66%), white (61%), and single (66%). The majority 
identified their orientation as heterosexual or straight (64%). Most had already initiated 
some form of sexual activity (83%) and had between one and five lifetime sexual partners 
(56%) at the time of survey. Most reported having insurance coverage (78%). No 
statistical differences were evident between Hispanic and non-Hispanic participants 
regarding age, gender, sexual orientation, lifetime sexual experiences, relationship status, 
or insurance status (Table 1). 
Baseline 
Awareness and Knowledge 
Hispanic participants (86%) were more likely than non-Hispanic participants 
(78%) to have heard of HPV prior to the intervention (P=0.05). Non-Hispanic (63%) 
participants were more likely than Hispanic participants (54%) to report receiving at least 
some information about HPV prior to the intervention, although this difference was not 
significant at the 95% confidence level (P=0.06).  
Twenty-one percent of Hispanic males had never heard of HPV before the 
intervention experience and 58% reported receiving no information about HPV (similar 
to non-Hispanic men) compared with 41% of Hispanic women (P=0.02). When asked 
“How much would you say you know about HPV?” about a third of Hispanic and non-
Hispanic participants described their knowledge as “moderate” or “a lot”. Regarding 
HPV vaccination, 32% of participants reported moderate to high self-perceived 
knowledge. At baseline, 70% of all participants received low scores (<4/7) on HPV 
knowledge, with no difference by ethnicity. 
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Vaccine Uptake 
While 41% of respondents reported receiving at least one dose of HPV vaccine, 
only 20% of respondents had received three doses (Figure 1). Forty-one percent of 
Hispanic participants reported having one or more doses of HPV vaccine, a similar 
percentage as non-Hispanic participants (39%, P>0.05). Hispanic women (48%) were 
more likely than Hispanic men (27%) to have received at least one dose of HPV vaccine 
(P=0.006), but non-Hispanic men and women were equally likely to report receiving at 
least one dose (P>0.05). 
Vaccine Attitudes 
Regardless of ethnicity, 69% of participants reported that HPV was a serious 
concern for women, while only 47% reported that HPV was a serious concern for men. 
Hispanic men were significantly more likely than Hispanic women to be unsure regarding 
many of the attitude questions. Fifty-seven percent of Hispanic men reported being 
unsure if HPV was a rare infection. Despite this, 39% percent of Hispanic men were 
unsure if HPV was a serious concern for women, while 49% were unsure about the threat 
to men. 
The majority of participants (72%) reported positive attitudes toward general 
vaccine safety and effectiveness. Hispanic students (62%) were more likely to have a 
positive opinion at baseline of the HPV vaccine (versus 44%, P=0.009), and more likely 
(66%) than non-Hispanic students (46%) to be willing to take the HPV vaccine if not 
already vaccinated (P=0.02). Hispanic students were more likely than non-Hispanic 
students to report that women (74% versus 62%, P=0.04), and to a lesser extent, men 
(68% versus 58%, P=0.04) should be vaccinated against HPV. Twelve percent of 
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participants who agreed that women should be vaccinated against HPV disagreed or were 
unsure if men should be vaccinated. Two-thirds of Hispanic participants (67%) agreed 
with the statement “everyone should be vaccinated against HPV” compared with 55% of 
non-Hispanic participants (P=0.04). Non-Hispanic men (37%) were less likely to believe 
that everyone should be vaccinated against HPV than non-Hispanic women (61%, 
P=0.03).  
Post-Intervention 
Knowledge 
Immediately after the intervention, participants showed a statistically significant 
improvement in knowledge and attitudes toward HPV and vaccination. When asked again 
about their self-perceived knowledge of HPV, 94% of those who felt limited knowledge 
 at baseline felt they knew more following the intervention. Similarly, 91% felt 
more knowledgeable about the HPV vaccines following the intervention. Participants 
improved their average knowledge score from 2.4 points (SD=2.0) to 5.3 (SD=1.5) out of 
seven (P<0.001). There was no difference in post-intervention knowledge score between 
ethnicities after means were adjusted for pre-intervention score F(1, 349)=.276, P=.60. 
Further stratification by gender showed that men, regardless of ethnicity, performed just 
as well as women on the post-test despite earning slightly lower baseline knowledge 
scores (Fig. 2). Individual item analysis showed that participants significantly improved 
in each knowledge measure except one. At post-test 46% of participants still incorrectly 
answered that herpes was caused by HPV, despite this being an improvement from 83% 
incorrect at baseline.  
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Vaccine Attitudes 
 Consideration of HPV as a serious concern for women increased from 69% at 
baseline to 92% (Z=-10.2, P<0.001), and from 47% to 86% for men (Z=-8.2, P<0.001). 
Despite this, only 63% of women and 73.6% of men felt HPV was a threat to their own 
health. Hispanic participants were still more likely than non-Hispanic participants to 
agree that women (93% versus 86%, respectively; P=0.05) and men (92% versus 86%, 
respectively; P=0.05) should be vaccinated against HPV.  
 Attitudes toward general vaccine safety and effectiveness moderately increased 
following the intervention (from 72% in pre-test to 81%). Opinions of the HPV vaccine 
improved overall at followup, with non-Hispanic attitudes improving to 73%, yet not 
enough to close the significant attitude gaps seen at baseline compared to Hispanic 
participants (81%, P=0.04). 
Intervention Evaluation 
 No differences were found in evaluating components of the intervention. Both 
Hispanic and non-Hispanic participants found the intervention experience to be highly 
acceptable; 93% rated the overall intervention experience to be “positive” or “very 
positive”. When assessing each component of the intervention, 96% of participants found 
the educational presentation to be an appropriate length. Ninety-eight percent felt the 
question and answer session that followed the educational portion to be useful, and 97% 
felt they learned a great deal from their participation.  
Discussion 
College students aged 18-26 are in a unique position to participate in catch-up 
HPV vaccination and should be educated on HPV and vaccination options. A brief HPV 
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educational intervention administered to ethnically diverse, undervaccinated young adults 
can potentially improve vaccination rates. HPV knowledge and attitudes can significantly 
be altered; gender and ethnic disparities can be dramatically reduced. 
Baseline knowledge of HPV and HPV vaccination was equally low in our sample 
of undergraduate students. Women had similar baseline knowledge of HPV and HPV 
vaccination as their male counterparts, which was a surprising finding, given that the 
vaccine was initially intended and marketed for women and girls.27 Several studies to find 
women surpassing men in HPV-related knowledge.28,29 Vaccine initiation (≥1 dose) in 
Hispanic students was 41%, similar to non-Hispanics in this sample, despite reporting 
receiving less HPV-related information prior to involvement in the intervention. Hispanic 
adolescents surveyed in a 2015 Florida study reported 61.7% of women and 50.1% of 
men having received at least one dose of HPV vaccine.,30 a higher coverage than 
observed in our study. Results at our university fall well below national HPV vaccine 
coverage of 63% for adolescent women, and far below the 80% coverage rate needed to 
see real reductions in the medical burden of HPV. 
Despite finding similar rates of vaccine initiation in Hispanic and non-Hispanic 
participants in our study, there were significant differences in the way Hispanic 
participants viewed HPV vaccination compared to non-Hispanic participants, which 
extended into differences in willingness to become vaccinated in the future. Several 
studies describe Hispanic vaccine consumers as being wary of side effects,3,4 though we 
found Hispanic students to have more positive views of HPV vaccination. This may be 
explained by a burgeoning hesitancy to vaccines among non-Hispanic whites, who rely 
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less on the medical opinions of doctors than Hispanics to help them make vaccination 
decisions.31  
Hispanic participants were more likely to believe that HPV is a serious concern, 
and expressed more willingness to become vaccinated if not already. Hispanic 
participants also reported receiving less information on the topic of HPV and HPV 
vaccination, even with similar insurance coverage as non-Hispanic participants. In 
addition, Hispanic participants had more positive views of the safety and effectiveness of 
vaccination in general. These observations suggest that Hispanic students would have 
higher vaccine coverage than non-Hispanic students if they were provided with the 
amount of information that non-Hispanic students reported receiving before the 
intervention. Nevertheless, Hispanic positive attitudes toward vaccination in general as 
well as toward HPV vaccine may not be enough to influence vaccine coverage rates 
among Hispanics in Florida and can be greatly improved. 
There were several limitations in this study. It was conducted at a single HSI with 
students enrolled in a limited number of classes. Enrolled students may not be 
representative of the community or the population of college students in south Florida. 
Results of this study should not be generalized to other universities or the south Florida 
community without due caution. We recruited from a region known to have a large 
Cuban population; while identifying themselves primarily as Hispanic, we cannot 
generalize our findings to non-Cuban Hispanic populations due to sociodemographic and 
other differences between Cubans and other Hispanic nationalities. Our assessments were 
conducted at baseline and immediately post-intervention, so sustainable changes in 
knowledge, favorable attitudes, and vaccine acceptance were not determined. Vaccination 
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status was not assessed again in the weeks after the intervention, so we were unable to 
make any claims that the intervention prompted undervaccinated participants to become 
vaccinated.  
Comparison groups could be utilized in future studies to determine the 
comparative efficacy of a brief educational intervention to other prevention strategies. 
Future studies assessing the role of education on HPV knowledge and attitudes should 
include more measures on ethnicity and pre-existing vaccination stances so that factors 
related to vaccine intentions can be thoroughly assessed. Providers should prioritize 
young adults during routine health screenings, and work to minimize missed 
opportunities for vaccination in a culturally competent and inclusive manner. Particular 
care should be taken to tailor HPV educational messages for Hispanic young men and 
women in both clinical and non-clinical settings. 
Conclusions 
HPV-related knowledge and attitudes can be improved through a brief, tailored 
and culturally competent educational intervention experience in a college setting. 
Differences between Hispanic and non-Hispanic students at baseline disappeared at 
posttest, suggesting that culturally tailored educational materials are a meaningful method 
for addressing knowledge disparities in ethnic minority communities. Our findings also 
highlight the ongoing implications of vaccine-hesitant attitudes, despite the proven safety 
and effectiveness of HPV vaccines. While our approach was successful in bridging a gap 
for participants with vaccine-hesitant attitudes, more comprehensive strategies might be 
needed in the future to reach 80% HPV vaccination rates nationwide. 
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Tables 
 
Table 5.1. Sociodemographic Characteristics of Participants by Ethnicity. 
Characteristics  
Total                      
N=382 
Hispanic               
n=252 
Non-
Hispanic                 
n=129 
 Mean(SD) Mean(SD) Mean(SD) 
Age, y 22.4(5.0) 22.2(4.5) 22.6(5.4) 
 n n(%) n(%) 
Sexual Orientation    
     Straight 244 154(61.4) 90(70.3) 
     Gay/Lesbian 66 48(19.1) 18(14.1) 
     Bisexual 53 36(14.3) 17(13.3) 
     Other 16 13(5.2) 3(2.3) 
Race    
     White 233 197(77.9) 36(27.9) 
     Black 82 15(5.9) 67(51.9) 
     Other 67 41(16.2) 26(20.2) 
Lifetime Sexual 
Partners  
   
     0 54 36(14.3) 18(14) 
     1-5 214 150(59.8) 64(49.6) 
     6-10 55 32(12.7) 23(17.8) 
     >10 57 33(13.1) 24(18.6) 
Health Insurance     
     Insured 234 158(79.4) 76(74.5) 
     Uninsured 52 30(15.1) 22(21.6) 
     Don't Know 15 11(5.5) 4(3.9) 
Relationship status     
     Single 254 162(64.0) 90(69.8) 
     Married 16 10(4.0) 6(4.7) 
     
Divorced/Widowed 
4 2(0.8) 2(1.6) 
     In a Relationship 110 79(31.2) 31(24.0) 
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Figures 
 
Figure 5.1. HPV Vaccine Initiation and Completion Rates by Gender and Ethnicity. 
 
 
 
 
 
 
 
 
 
 
  
 76 
 
Figure 5.2. Change in Mean Knowledge Score From Baseline to Post-Intervention by 
Ethnicity and Gender. 
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CHAPTER VI 
Impact of a brief educational HPV intervention among sexually diverse college 
students 
Abstract 
Self-identified lesbian, gay, bisexual, transgender, or queer (LGBTQ; n=131, 43.5%) and 
heterosexually-identified (HSI; n=170, 56.9%) students enrolled in gender studies 
courses at a Florida university from 2015 to 2017 completed a questionnaire regarding 
human papillomavirus (HPV) and HPV vaccine knowledge, attitudes, and practices. 
Women who have sex with women (WSW; 88%) were just as likely as HSI women 
(86%) to have heard of HPV, received any doses of HPV vaccine (42% vs 46%, 
respectively), and positively view HPV vaccination (62% vs 59%, respectively); yet were 
more willing to be vaccinated than HSI women (71% vs 53%; P=0.04). Similarly, men 
who have sex with men (MSM, 50%) were just as likely as HSI men (41%) to believe 
HPV is a serious concern for men and that men should be vaccinated (73% vs 58%; 
P>0.05). Nevertheless, MSM (92%) were more likely than HSI men (68%) to have heard 
of HPV, to receive any doses of HPV vaccine (37% vs 19%), positively view HPV 
vaccination (58% vs 39%), and were more willing to be vaccinated (86% vs 39%; 
P≤0.05). LGBTQ students have positive views towards HPV vaccination and are more 
interested in becoming vaccinated than heterosexual students, but require prevention 
information and education pertinent to their particular health needs. Opportunities to 
engage, educate, and vaccinate sexual minority young adults should be capitalized upon. 
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Introduction 
High-risk, oncogenic human papillomavirus (HPV) subtypes can cause cancers of 
the cervix, genitals, anus, and oropharynx. Low-risk, non-oncogenic subtypes can cause 
genital warts.1 Cervical cancer has prevailed for decades as the clinical paradigm for 
cancer caused by HPV, with an established clinical framework for screening and 
treatment in women.2 Recent evidence has established the natural history of 
oropharyngeal cancers in high-risk groups, and indicates substantial biological homology 
to the relationship between cervical cancer and HPV. 
Although there are many acceptable terms used to refer to lesbian, gay, bisexual, 
and transgender people, we will use the acronym LGBTQ (lesbian, gay, bisexual, 
transgender, questioning) when collectively describing those who identify as sexual 
minorities, and HSI (heterosexually-identifying) to describe those who self-identify as 
heterosexuals. The terms men who have sex with men (MSM) and women who have sex 
with women (WSW) will be used to describe those who self-report as sexual minority 
males and females, respectively. The terms lesbian, gay, and bisexual are used when we 
are able to delineate specific differences.  
LGBTQ are a medically underserved, priority health group, and require specific 
attention.3 The majority of school-based sexual education programs are not 
comprehensive and typically omit LGBTQ sexual health topics. By the time they reach 
college age (18-26 years), MSM and WSW will have already experienced a multitude of 
sexual health inequities which put them at elevated risk for HPV outcomes, often 
complicated by reluctance to share information about their sexual orientation with 
healthcare providers.3,4 MSM in particular have higher rates of HPV infection and disease 
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than HSI men; a 2016 study estimated 78% of HIV-negative MSM had anal HPV 
infection and 35% of these infections were found to be cytologically abnormal, a higher 
rate than HSI men’s infections.5 Positive HIV status increases the risk for anal HPV 
infection among MSM. Fewer studies examined HPV-related topics among WSW, who 
are at higher risk for HPV infection than HSI women.6 None were interventions. Despite 
this shortcoming, a common misconception is that sexually active WSW are at less risk 
due to underestimation of prior heterosexual infection, reduced likelihood to receive Pap 
testing, and MSM-dominated sexual health promotion efforts.7,8 From 2003-2012, an 
estimated 49.7% of WSW were infected with any HPV, compared with 41% of HSI 
women, with even larger differences for oncogenic high-risk types (37.7% in WSW vs. 
28.2% in HSI women).9 Evidence also suggests that like MSM, WSW have a higher 
prevalence of oral HPV infection than HSI women.10 
The 9-valent vaccine against HPV is recommended in the U.S. to prevent genital 
warts and HPV-related cancers, including cervical and oropharyngeal.11 The Advisory 
Committee on Immunization Practices (ACIP) currently recommends routinely 
vaccinating 9-14-year-old children on a 2-dose schedule, regardless of gender, and 
providing catch-up vaccination for women until ages 21-26. Men should receive catch-up 
vaccination until age 21. For MSM, the ACIP recommends routine HPV vaccination 
through age 26. Bisexual women have a higher odds of vaccine initiation and completion 
than lesbian and HSI women.4,12 Gay men have higher odds than HSI and bisexual men,12 
with an estimated 21% of MSM and 45% of WSW receiving at least one dose.13,14 
Several affiliations strongly advocate for HPV vaccination to be established as a national 
priority.15,16 They suggest that advancement of research on effective HPV educational 
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interventions be conducted. Two recent systematic reviews of interventions to increase 
vaccine uptake found no interventions tailored for LGBTQ college students.17,18 Future 
HPV interventions should emphasize cultural competence to influence HPV vaccine 
uptake among diverse groups.  
Positive HPV vaccine attitudes are a predictor of vaccine uptake, along with 
provider recommendation and older age.13,19 Most studies find LGBTQ young adults to 
be lacking in knowledge.20,21 Here we report on a brief, tailored intervention designed to 
educate sexually diverse college students about HPV and promote HPV vaccination as a 
safe and effective means of prevention. We describe immediate effects on HPV-related 
awareness, knowledge, and attitudes, as well as the acceptability of the intervention in a 
sexually diverse sample. 
Methods 
The educational intervention was designed to improve knowledge and attitudes 
regarding HPV and HPV vaccination. The project was piloted in its entirety in April 
2015. The project took from 30-45 minutes to complete, including a pretest, moderated 
educational presentation, question and answer session, and an immediate posttest. The 
self-administered written pre-/post-tests elicited self-perceived and measured knowledge 
about HPV, as well as attitudes regarding severity, susceptibility, benefits, and barriers 
related to HPV and HPV vaccination. 
We recruited during four semesters of an undergraduate gender studies course 
from the spring 2015 to spring 2017 semesters. In addition, we recruited from three 
undergraduate dietetics and public health courses in January and February of 2017. Every 
member of the seven classes who attended on the day of data collection was asked to 
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participate (total enrollment=409 students) and was provided with a statement regarding 
consent. Students under the age of 18 were excluded from study participation. The 
university’s Institutional Review Board approved the study protocol prior to 
implementation. 
The matched pre- and post-questionnaires consisted of a total of 62 items (38 
pretest, 24 posttest). It was adapted in March 2015 from the 2009 University of North 
Carolina Men’s Health Survey (100 items),22,23 with additional questions derived from a 
review of relevant scientific literature, using constructs of the Health Belief and 
Transtheoretical Models as a theoretical guide. Questionnaires were pre-tested in a focus 
group of seven graduate public health students and was subsequently revised. Pretests 
and posttests were matched by numerical identifiers. No personal identifying information 
was requested or recorded. 
Each questionnaire took approximately 5-10 minutes to complete. At baseline, we 
asked participants to self-report information about their sociodemographic characteristics 
(age, gender identity, ethnicity/race, health insurance status, sexual orientation, 
relationship status, sexual practices, number of partners), awareness of HPV, HPV 
vaccine experiences, and willingness to become vaccinated if not already completely 
protected. Participants were then asked to rate their self-perceived knowledge of HPV 
and HPV vaccines. Eleven questions (six from UNC Men’s Health Survey, five adapted 
from the literature) measured attitudes toward various HPV-related statements on a five-
point Likert scale ranging from “strongly agree” to “strongly disagree” with an additional 
“don’t know” option. We measured actual HPV knowledge with seven true/false items, 
four of which were adapted from UNC’s Men’s Health Survey.  
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Following the baseline questionnaire, the evidence-based presentation contained 
26 PowerPoint images and messages that introduced general information about HPV, 
including subtypes, transmission, infection outcomes, diagnosis, treatments, prognosis, 
and vaccination/prevention options. The educational presentation was tailored to diverse 
young adults by incorporating gender neutral and orientation-sensitive language. 
LGBTQ-positive images with multicultural ethnic representation were shown. All 
knowledge items assessed in the pre- and post-test questionnaire were addressed in the 
presentation. The question and answer sessions immediately followed the presentation, 
usually lasted about ten minutes, and allowed students to ask more specific, often 
situational questions. The participants then completed the posttest, which included 
followup knowledge and attitude questions identical to the pretest with additional 
questions regarding participants’ experience with the intervention. Students received 
tokens of appreciation such as pens, pencils, lip balm, and condoms. 
Analysis 
All analyses were performed using Statistical Package for the Social Sciences 
(version 22.0).24 Statistical significance was set at P<0.05. Reliability assessment of the 
pre and post knowledge score and attitude scales were conducted using Cronbach’s alpha. 
We report percentages for the complete sample, and percentages (n/N) when analyses 
contain missing data. Univariate frequencies were calculated for sociodemographic 
variables in the entire sample, and then examined by self-reported gender and orientation 
(LGBTQ versus HSI) to determine if there were differences between groups. Responses 
were collapsed into dichotomous outcomes where appropriate. Attitude items were coded 
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such that “strongly agree” or “agree” corresponded to a positive attitude toward that 
topic.  
Pearson’s Chi-Square or Fisher’s exact tests were performed to determine 
differences between and among LGBTQ and HSI groups for categorical items. We 
calculated the mean knowledge score at baseline and followup, and performed one-way 
ANOVA with Tukey’s post-hoc analysis to determine if baseline mean scores differed by 
binomial orientation.25,26 Differences between groups in baseline attitude score was 
analyzed with Mann-Whitney-Wilcoxon test by gender.27,28 Participants who responded 
“don’t know” to baseline knowledge questions were further examined with a 
nonparametric binomial test to determine how they responded following the 
intervention.29 Intervention effects on knowledge and attitude were tested using a 
repeated measures ANOVA with Greenhouse-Geisser correction, with partial eta squared 
measuring effect size of the intervention.30,31 Post-hoc Tukey tests determined if the mean 
change in scores differed by orientation groups. 
Results 
Of the 409 students enrolled in the seven classes, 390 (95%) completed the 
baseline questionnaire, and 364 (89%) completed both a baseline and a posttest 
questionnaire and answered the two questions regarding self-identified gender and sexual 
orientation. Most participants (n=232, 64%) self-identified as heterosexual, 132 (36%) 
identified as LGBTQ. LGBTQ were more likely to be enrolled in the gender studies class 
(43%) than in the Dietetics and Nutrition classes (1%). Participants had a mean age of 
22.5 years (SD=5.16), and identified mostly as female (70.8%). Approximately two-
thirds were Hispanic (66.7%) and single (65.9%). Over half identified their race as white 
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(61.0%). Over half (57%) reported between one and five lifetime sexual partners at the 
time of survey. Fifty-three (15%) reported having no lifetime sexual partners. Students 
reported ever having more oral (82.9%) and vaginal (71.7%) lifetime sexual experience 
than anal sex experience (36.5%). Over three-fourths reported having health insurance 
coverage (78.9%; Table 1). 
LGBTQ students were similar to HSI students regarding age, race and ethnicity, 
and insurance status, (P>0.05). LGBTQ (89%) were just as likely as straight students 
(83%) to have heard of HPV and to have received at least one dose of HPV vaccine (40% 
vs 42%, respectively). Almost half (46%) of LGBTQ students did not know their HPV 
vaccination status compared with 35% of straight students (NS). Despite this, LGBTQ 
students were more likely to have positive attitudes toward HPV vaccination (77% vs 
66%; P=0.03). In addition, LGBTQ students were more willing to receive the HPV 
vaccine (79% vs 58%, respectively; P=0.02), and more likely to believe men should be 
vaccinated (75% vs 57%, respectively; P=0.002).  
Men’s HPV Awareness and Vaccine Uptake 
MSM were more likely to report greater than ten lifetime sexual partners than HSI 
men (37% vs 18%, respectively, P=0.047). Regarding awareness of HPV, 92% of MSM 
had heard of HPV compared to 74% of HSI men (P=0.03). HSI men (39%) were more 
likely to have received zero doses of HPV vaccine than MSM (15%, P=0.035; Figure 1). 
HSI men (70%) were more likely than any other orientation group (average of 45%) to 
report receiving little to no information about HPV prior to the intervention experience 
(P=0.001; Table 2). At baseline, MSM were more willing than HSI men to become 
vaccinated against HPV if not already (85% vs. 40%, respectively; P=0.001), despite no 
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differences being reported between the two groups regarding insurance coverage.  
Men’s Knowledge and Attitudes 
At baseline, men’s mean knowledge score differed significantly by orientation 
(F(2,106)=5.32, P=0.006), with HSI men scoring lower than gay men (P=0.005). There 
was no significant difference in mean baseline score between bisexual men and HSI or 
gay men (P>0.35; Figure 3). Men’s mean HPV knowledge scores significantly increased 
following the intervention (Wilk’s Lambda=0.34, F(2, 95)=184.7, P<0.001, partial eta 
squared= 0.66). Gay men’s mean score change from baseline to post-test was 
significantly larger than HSI men (Tukey’s HSD, P=0.03; Table 3). 
Regarding the HPV vaccine attitudes scale, we found that although MSM reported 
more positive views than HSI men at baseline, the differences in distributions of median 
scores did not differ significantly at baseline (U=418.5, Z=-1.76, P=0.08) or post-test 
(U=652.5, Z=-0.76, P=0.45; Figure 4). Individual item analysis, however, showed that 
baseline differences lay with certain questions. MSM were more likely than HSI men to 
have a positive opinion of HPV vaccination (70% versus 44%, P=0.03), and think 
everyone should be vaccinated against HPV (83% versus 61%, P=0.02), despite 70-72% 
of both groups having positive views of vaccines in general. At post-test, there remained 
a significant difference in their opinion of HPV vaccination, with MSM men (88%) still 
more likely to have a positive opinion than HSI men (67%, P=0.03). Men’s attitudes 
improved significantly following the intervention, with no differences by sexual 
orientation (Wilk’s Lambda=0.34, F(1, 54)=106.6, P=0.00, partial eta squared= 0.66). 
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Women’s HPV Awareness and Vaccine Uptake 
Women of all orientations reported similar numbers of sexual partners (59-63% 
reported 1-5 partners). WSW (88%) were just as likely as HSI women (86%) to have 
heard of HPV, received any doses of HPV vaccine (42% vs 46%, respectively), but 
expressed more willingness to be vaccinated (71% vs 53%; P=0.04). 
Women’s Knowledge and Attitudes 
  Baseline knowledge score differed significantly between women’s orientation 
groups (F(2,250)=4.19, P=0.016). Specifically, lesbian and bisexual women’s baseline 
mean scores significantly differed (Tukey’s HSD, P=0.01). Bisexual women scored the 
highest on baseline HPV knowledge with an average of 45% correct, followed by HSI 
(39%) then lesbian women (28%). From baseline to post-test, women’s overall mean 
HPV knowledge score increased (Wilk’s Lambda=0.37, F(1, 241)=411.56, P=0.00, 
partial eta squared= 0.63), with no differences in knowledge score mean change between 
HSI, lesbian, and bisexual women (P≥0.09; Figure 5). 
 In response to the HPV vaccine attitudes scale, WSW and HSI women had similar 
scores at baseline (28/40 points; U=1696.5, Z=-1.87, P=0.06). Women’s mean change in 
attitude score shifted significantly in a positive direction following the intervention 
(Wilk’s Lambda=0.53, F(1, 132)=118.1, P<0.001, partial eta squared= 0.47; Figure 6). 
Bisexual women’s mean change was significantly larger than HSI women’s (Tukey’s 
HSD, P=0.01), with no significant difference between HSI and lesbian or bisexual and 
lesbian women (P≥0.2; Table 3). 
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Intervention Evaluation 
 At post-intervention reassessment, participants also rated the intervention and its 
key components. Regarding the overall intervention experience, 93% of all participants 
rated the intervention experience “positive” or “very positive.” Participants (97%) felt 
they learned much from the educational presentation, and 95% found the presentation to 
be an appropriate length when given the choice between that or “too long” or “too short”. 
Almost all (98%) participants found the questions and answer session “helpful” or “very 
helpful”. Subgroup analyses yielded no differences by gender or sexual orientation in the 
evaluation of the intervention elements. 
Discussion 
As serious HPV-related outcomes become more commonplace, especially among 
LGBTQ, we must determine the impact of HPV education in risk-reduction and 
prevention on sexually diverse intervention participants. Governmental and non-
governmental health organizations are increasingly calling for efficacious interventions to 
address a myriad of factors related to HPV prevention16,32–34 amidst troublingly low HPV 
vaccination coverage. Few established interventions focus on the impact of participation 
on the LGBTQ community. Fewer still focus on adolescent or young adult LGBTQ, and 
not one has targeted the WSW community.35,36  
We developed and evaluated the acceptability and efficacy of a brief HPV 
educational intervention designed to inform and encourage HPV vaccination among 
diverse college students. Young adults who were exposed to the intervention showed 
immediate knowledge and attitude improvements. Our pre-post intervention design 
evaluated two specific intervention outcomes between groups. The largest effect sizes 
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were in knowledge of HPV. We found smaller, yet still significant effects in attitudinal 
measures regarding general and HPV vaccine acceptability and perceived threat of HPV. 
In addition to overall intervention efficacy, we found significant between group 
differences by sexual orientation. HSI men in our sample reported receiving less 
information about HPV than MSM prior to the intervention and reported lower levels of 
HPV knowledge and less positive vaccine attitudes at baseline. At followup evaluation, 
HSI men reported significantly lower gains in knowledge than MSM. This finding is 
consistent with research on multidimensional education programs, which find more 
reliable immediate effects on knowledge than on attitudinal measures.37,38 Whereas HPV 
knowledge improved immediately after information is provided, changes in strong 
attitudes toward vaccination may require larger intervention doses to permanently affect 
outcomes, despite knowledge being an important determinant in attitude formation and 
subsequent vaccine intentions and behaviors.  
Our findings among men agree with previous investigations into HPV knowledge 
and with the few HPV interventions targeting MSM. Prior to the recommendation for 
men to also become vaccinated against HPV in 2011, Gerend et al. found that HSI men 
were resistant to messages regarding partner protection against HPV, with intervention 
treatment participants reporting similar acceptability of the HPV vaccine to the control 
group.39 McRee et al. documented relatively high HPV knowledge among MSM. 
However, they did not have an HSI comparison group.36 Young MSM in their 2016 
online intervention were over twice as likely as the control group to initiate HPV 
vaccination. Our findings suggest that HSI may not see HPV as a serious threat. 
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Conversely, we found that lesbian women had the lowest mean knowledge score 
among women (but still higher than that of HSI men), and the lowest mean HPV attitude 
score of all the groups regardless of gender. Bisexual women had more positive attitudes 
toward HPV vaccination, and bisexual women also had the highest knowledge at baseline 
among all groups. Women in our study were more likely to identify as bisexual than men. 
This is supported by national datasets in which women have a greater probability than 
men of being bisexual, whereas men are more likely to report being either heterosexual or 
homosexual.40 Our study indicates that bisexual women are above average in HPV 
knowledge and willingness to become vaccinated, despite being just as likely as HSI and 
lesbian women to have heard of HPV and initiate vaccination. This is reflected in 
previous studies assessing HPV vaccine uptake among WSW,4 with lesbian women 
tending to be less prevention-oriented in their health behaviors due to misconceptions 
about risk.  
We found no interventions tailored specifically for WSW, despite their 
designation as a special health population.41 This indicates that WSW are not prioritized 
in HPV prevention, though lesbians tend to manifest multiple sexual health risk 
indicators, such as lack of knowledge and lower likelihood of pap testing or HPV 
vaccination.4,8,14 Lesbian women, who are continually left out of sexual health education 
and prevention messaging,6 displayed high potential for knowledge retention and positive 
attitudinal change as seen at post-intervention assessment. This could be attributed to the 
LGBTQ-inclusive material presented to the participants. Despite receiving low 
knowledge scores, lesbian women reported being just as frequently vaccinated as HSI 
women, suggesting lesbian women either face barriers in health seeking behaviors, or are 
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systematically overlooked in HPV education and prevention.42 The socially-accepted idea 
that HPV as transmitted only via penetrative sex acts (involving a penis) conflates sexual 
orientation and risk. This inaccuracy suggests that sexually active heterosexuals and 
MSM are exclusively at risk, and is problematic for preventive efforts among WSW. 
Tailored HPV education targeting sexually diverse college students is not only 
efficacious but also wanted and needed. Participant attitudes toward the in-class 
educational intervention experience were very positive. Ratings of each component of the 
intervention were very high, with no differences by gender or sexual orientation. 
Limitations 
The positive results of this initial outcome evaluation indicate that the 
intervention should be evaluated more rigorously in a multicenter randomized controlled 
trial. In lieu of a control group, we assessed change with a pre-post design. Post-
intervention outcomes were assessed immediately after exposure to the intervention. As 
such, it is possible that improvements in HPV knowledge and especially attitude could 
regress over time as we use only one brief session to deliver the intervention. Future 
studies should employ a third evaluation to characterize effects over a longer follow-up 
period. Finally, we relied on participants’ self-reported knowledge and attitudes, which is 
subject to recall, response, and social desirability bias. Utilizing a brief intervention 
methodology, it was not possible to include behavioral outcomes such as initiation or 
completion of HPV vaccination. Future studies should assess intention to vaccinate or 
HPV vaccination behaviors as an outcome of the intervention and explore knowledge and 
attitude as correlates of behavioral intentions and subsequent vaccine uptake. 
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Conclusion 
LGBTQ students have positive views towards HPV vaccination and are interested 
in becoming vaccinated, but require prevention information and education pertinent to 
their health needs. Opportunities to engage, educate, and vaccinate sexual minority young 
adults should be capitalized upon while still prioritizing HSI men as a group in need of 
intensive and reinforced HPV education. 
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Tables 
Table 6.1. Participant Soiciodemographic Characteristics by Orientation. 
 Male   
 Female 
Variable 
HSI 
(n=64) 
Gay 
(n=34) 
Bisexual 
(n=11) 
P-
value 
 
HSI 
(n=184) 
Lesbian 
(n=31) 
Bisexual 
(n=42) 
P-
value 
 
  
Age (Mean, SD) 24(6.7) 21(2.1) 20(1.0)   23(5.0) 22(3.3) 21(3.6)   
Race/Ethnicity 
   0.07 
 
   0.14 
       Non-Hispanic 
White 
9(14.5) 2(6.3) --   16(9.5) 2(7.1) 4(11.1) 
 
       Hispanic 37(59.7) 27(84.4) 9(81.8)   116(68.6) 20(71.4) 25(69.4) 
 
       Black 16(25.8) 3(9.4) 2(18.2)   37(21.9) 6(21.4) 7(19.4) 
 
Relationship Status 
   0.9 
 
   0.33 
       Single 45(70.3) 26(76.5) 8(72.7)   109(67.7) 19(61.3) 30(71) 
 
       Married 3(4.7) 1(2.9) --   10(6.2) -- 2(5) 
 
       
Divorced/widowed 
1(1.6) -- --   30(18.6) -- -- 
 
       In a relationship 15(23.4) 7(20.6) 3(27.2)   12(7.5) 12(38.7) 10(24) 
 
Insurance Status 
   0.07 
 
   0.21 
       Insured 42(79.2) 22(84.6) 9(34.6) 
  117(78) 16(84) 20(69) 
 
       Uninsured 10(18.9) 0(0) 1(3.8) 
  29(19) 3(16) 7(24) 
 
       Don’t Know  1(1.9) 4(15.4) 0(0) 
  5(3) -- 2(7) 
 
Lifetime Sex 
Partners    
0.003  
   
0.1 
       0 11(17.2) 3(8.8) --   26(14) 2(7) 5(39) 
 
       1-5 30(46.9) 13(38.2) 3(27.3)   115(64) 20(65) 5(39) 
 
       6-10 9(14.1) 4(11.8) 5(14.7)   23(13) 26(62) 1(8) 
 
       >10 14(21.9) 14(41.2) 3(8.8)   17(9) 5(39) 2(15) 
 
Vaginal Sex 
Experience      
44(69) 5(16) 7(70) <0.001  150(82) 27(87) 33(79) 0.22 
Oral Sex Experience 50 (79) 30(88) 10(100) 0.005  147(82) 29(94) 37(88) 0.05 
Anal Sex Experience  12(20) 29(85) 10(91) <0.001  55(32) 8(30) 2(17) 0.62 
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Table 6.2. Item-Wise Post-Test Response of Participants Who Responded "Don't Know" 
at Baseline. 
 
Item 
n(%) Don’t 
Know baseline 
Post-Test Response n(%) 
Correct  Incorrect P-value 
Q1.HPV infection is rare  167(43.6) 136(96%) 5(4%) 0.00 
Q2. HPV causes herpes  218(58.3) 114(57%) 86(43%) 0.06 
Q3. AIDS is caused by HPV 191(50) 132(75%) 43(25%) 0.00 
Q4. The only way to protect 
yourself from HPV is to use 
a condom 
142(37.2) 121(92%) 10(8%) 0.00 
Q5. Some strains of HPV are 
harmless 
223(58.4) 164(80) 40(20) 0.00 
Q6. HPV infection can cause 
cancer 
193(50.7) 169(95%) 9(5%) 0.00 
Q7. Student Health Services 
offers HPV vaccination 
284(74.9) 225(96%) 9(4%) 0.00 
     
*nonparametric Binomial 
test     
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Table 6.3. Baseline and Post-Intervention Outcome Mean Scores by Sexual Orientation 
Group. 
            
 
Knowledge  
M(SD)  
Attitude 
M(SD) 
  Baseline Followup   Baseline Followup 
Male      
     HSI 0.24(0.25) 0.81(0.16)  27(4.72) 34.3(5.32) 
     Gay 0.43(0.30) 0.89(0.12)  27.9(4.78) 36.8(4.15) 
     Bisexual 0.36(0.35) 0.79(0.19)  29.8(2.39) 36.8(1.9) 
Female      
     HSI 0.39(0.27) 0.86(0.15)  27.5(3.78) 34.2(4.58) 
     Lesbian 0.27(0.27) 0.85(0.13)  26.3(4.31) 35.8(4.75) 
     Bisexual 0.45(0.26) 0.85(0.13)  30.4(4.01) 36.9(2.98) 
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Figures 
Figure 6.1. Women’s HPV Vaccine Uptake by Orientation. 
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Figure 6.2. Men’s HPV Vaccine Uptake by Orientation. 
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Figure 6.3. Men’s Mean Knowledge Scores at Baseline and Post-Test by Orientation. 
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Figure 6.4. Men’s Mean Attitude Scores at Baseline and Post-Test by Orientation. 
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Figure 6.5. Women’s Mean Knowledge Scores at Baseline and Post-Test by Orientation. 
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Figure 6.6. Women’s Mean Attitude Scores at Baseline and Post-Test By Orientation. 
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CHAPTER VII 
Conclusions 
 This chapter summarizes the study and primary research findings as delineated in 
three unique manuscripts presented as Chapters IV, V, and VI. Presented here are also 
discussions of the primary findings, limitations, and recommendations for future research 
related to HPV in ethnically and sexually diverse young adults.  
Study Summary 
Despite the availability of safe and effective HPV vaccines since 2006, HPV 
vaccination rates continue to be subpar in the United States. Few studies have assessed 
the acceptability and efficacy of a brief educational intervention to promote HPV vaccine 
uptake in college students. Furthermore, no previous study has tested an educational 
intervention tailored for and targeting both ethnically and sexually diverse college 
students. This study was conducted among college students in a Hispanic-serving 
university in South Florida. Brief, evidence-based HPV presentations and question and 
answer sessions were delivered in conjunction with pre- and post-intervention 
assessments to appraise the educational intervention experience. The Health Belief Model 
and the Transtheoretical Model (or Stages of Change) were used to guide the study 
design, intervention content, and interpretation of the results. 
The purpose was to examine differences in HPV-related awareness, knowledge, 
and attitudes among diverse students both before and after exposure to a brief educational 
intervention. The first study described baseline differences in HPV-related awareness, 
knowledge, and attitudes between men and women enrolled in undergraduate courses. 
The second and third studies evaluated the differential efficacy of the educational 
 106 
 
intervention in improving HPV-related awareness, knowledge, and attitudes by ethnicity 
and sexual orientation.   
Discussion 
The first study examined baseline gender differences in HPV and HPV 
vaccination awareness, perceived and actual knowledge, and attitudes. Prior to 
experiencing the intervention, most participants (84%) had heard of HPV, and 70% had 
favorable attitudes toward HPV vaccination, yet there were significant gaps in vaccine 
uptake. Over half (55%) of women and only 28% of men had initiated the HPV vaccine 
series.  
Amidst generally low knowledge scores, those who reported receiving one or 
more doses of an HPV vaccine perceived themselves to be knowledgeable about HPV. 
The knowledge scores accurately reflected these perceptions. Attitude was positively 
associated with knowledge, in addition to being significantly associated with number of 
doses received among women, but not men. Although the percent of women who 
initiated HPV vaccination was below the state and national averages of 58% and 60% for 
young women, these percentages are still far below the desired 80% specified by the 
Department of Health and Human Services.1  
Disparate knowledge outcomes for young men and women are supportive of 
evidence finding behavior change is more likely to occur when individuals perceive 
themselves to be at risk or susceptible to the condition.2 Until recently, most men were 
oblivious to HPV-related issues as they weren’t directly affected by the primary outcome 
of cervical cancer, and the vaccine was intended for women only.3,4 Recently, over 40% 
of new cases of HPV-associated cancers were found in men.5 Since the ACIP released 
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recommendations for men to be vaccinated in 2011, men’s awareness and knowledge 
regarding HPV is slowly rising, yet still falls far behind that of women.36 Oropharyngeal 
and anal cancers, which are primarily diagnosed in men, are expected to increase as cases 
of cervical cancer decrease due to continued gender disparities in HPV knowledge and 
vaccination.83  
Few studies have assessed differences in vaccine attitudes among ethnic groups. 
A climate of vaccine hesitancy continues to grow in the United States, and there is 
limited evidence of intervention efficacy in changing such attitudes.84 The second study 
evaluated the differences in intervention effects between Hispanic and non-Hispanic 
students, with special attention paid to attitudes toward the safety and effectiveness of 
vaccines in general as a proxy measure of vaccine hesitancy.  
At baseline, 41% of Hispanic and 39% of non-Hispanic participants reported 
initiating the HPV vaccine series (NS). Hispanic participants (66% vs. 46% non-
Hispanic, P=0.02) were significantly more willing to become vaccinated against HPV if 
not already vaccinated, and more likely to express positive attitudes toward the HPV 
vaccine at baseline (62% vs. 44%, respectively; P=0.009). Hispanic men (21%) were less 
likely to know their vaccination status than all others. They were also less likely to report 
receiving any information about HPV (58%, P=0.02). Following the intervention, 
Hispanic and non-Hispanic men and women increased their knowledge scores by an 
average of almost 43%.  
Hispanic and non-Hispanic participants evaluated the components of the 
intervention as very positive.  Nevertheless, non-Hispanic students showed less favorable 
attitudes towards HPV vaccination following the intervention (86% vs >92% in Hispanic 
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students, P=0.04). In 10% of non-Hispanic cases (vs. 5% in Hispanic cases), participant 
attitudes were even more negative post-intervention than at baseline, indicating the 
intervention may have reinforced existing vaccine-hesitant attitudes among some students 
instead of counteracting them.  
Contradictory of early findings that Hispanics are wary of vaccine safety 
regardless of education level, the results of the second study suggest rather that poor 
attitudes toward vaccination among non-Hispanic whites are burgeoning, and is stronger 
than the wariness previously described in Hispanics.85  For example, in 1995, measles, 
mumps, and rubella (MMR) vaccination coverage was 2.8% lower among Hispanic 
children than non-Hispanic white children.86 MMR coverage increased from 87.9% in 
1995 to 92.4% in 2011 for Hispanic children, and became significantly higher than for 
non-Hispanic white children in 2010. According to assessments of medical records, 
however, Hispanics had a 4-fold greater odds of over-reporting vaccination receipt than 
non-Hispanic whites.87   
 While many HPV-related interventions have been designed and evaluated with 
MSM populations, there were no interventions which targeted WSW, and none which 
included heterosexual counterparts. The third study in this dissertation aimed to evaluate 
how intervention effects differed between MSM and WSW and compared with 
heterosexual men and women. There were significant differences between MSM and HSI 
in effects on knowledge and attitude, with gay men reporting stronger baseline 
knowledge and attitudes toward HPV, and retaining an advantage even after the 
intervention experience. Among women, those who identified as bisexual demonstrated 
higher knowledge scores than lesbian women at baseline, and had a significantly larger 
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change in attitudes following the intervention experience. These contrasting findings 
highlight the divergent HPV attitudes that women of different sexual orientations have, 
and call attention to the perceived normative beliefs regarding STI susceptibility that 
inform lesbian health propensities, and ultimately may be a barrier to HPV 
vaccination.88,89  
HPV educational efforts should place special emphasis on reaching heterosexual 
men and lesbian women, who lag behind other sexual orientation subgroups in 
knowledge and attitudes. There are no HPV interventions which are tailored for HSI men 
and lesbian women, which reflect national priorities in cancer prevention. Many studies 
cite provider recommendation barriers such as time constraints, low perceived threat to 
the patient, and even preferential vaccination recommendations.90 With the established 
importance of receiving a provider recommendation for HPV vaccination, healthcare 
providers may benefit from increased training on inclusive education of all vaccine-
eligible patients regardless of gender or orientation. 
Strengths and Limitations 
A limiting aspect of this study was the absence of a control or comparison group. 
The rigor of the study could have been maximized by assigning half of the course 
sections to the intervention as described, and the other half to a control arm receiving a 
standard practices pamphlet or other written information. Alternately, participants could 
have been randomly assigned to the intervention or control group following initial 
recruitment.  
For this intervention, a purposive sampling technique maximized 
sociodemographic diversity among participants. While purposive sampling methods may 
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be prone to researcher bias, the theoretical knowledge of the participants before the 
project made researcher bias negligible. The women’s studies course from which 
participants were recruited is historically known to have overrepresentation of LGBTQ 
individuals. Likewise, the university offering this course is known to have a Hispanic 
majority, being a Hispanic-Serving Institution. The actual class size and ratios of gender, 
ethnicity, or sexual orientation groups were unknown and beyond control in the 
participant recruitment process.  
The pre-/post-test design, especially in the context of a brief intervention, was a 
limitation and also a strength. Because the intervention did not extend beyond the 
confines of a single class period, we were unable to measure long-term outcomes, such as 
participant initiation or completion of the HPV vaccine series, or sustained knowledge 
and/or attitude improvements over time. Usually, this design also prevents researchers 
from establishing causality in the relationship between the intervention and outcome 
measures. However, due to the brevity of our design, we can be almost certain that the 
estimated effect can be attributed solely to our intervention.  
The study also depended on self-reported data from participants, which increases 
the likelihood that responses were subject to social desirability bias and recall bias. Since 
the HPV vaccine is at least a two-dose series over a six-month period, the chance of 
uncertainty among participants regarding number of doses received may be higher than if 
a single-time event were assessed, such as the flu vaccine. However, a study of self-
reported vaccine data compared to medical records found that HPV vaccine recall was 
over 90% accurate.87 
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Despite these limitations, the study had many strengths.  The intervention proved 
to be an excellent method for quickly improving knowledge and changing attitudes about 
HPV and HPV vaccination among diverse college students. The measures used to 
evaluate knowledge and attitudes demonstrated strong internal consistency.  
The participants received the intervention well, which was evident in the 
engagement of the students while the material was being delivered. Intervention 
acceptability was confirmed in the post-test evaluation of the intervention components, 
which all received positive scores ranging from 93-97% among participants. The 
intervention itself was inexpensive and easy to implement, making potential widespread 
use and adaptation feasible. 
Recommendations 
Lack of knowledge and poor attitudes regarding HPV and HPV vaccination 
among sexually and ethnically diverse college students are inhibiting HPV vaccine 
uptake in the United States. Heterosexual men, especially Hispanic heterosexual men, 
and lesbian women face substantial barriers in learning about HPV. Inclusive, 
comprehensive, judgement-free education, and the development of tailored and targeted 
intervention for those less likely to receive information from usual pathways can help 
improve vaccination rates in diverse populations of young adults. The combined effect of 
comprehensive education and purposeful intervention would be instrumental in 
addressing undervaccination, achieving acceptable vaccination rates, and controlling a 
highly preventable virus.   
Qualitative research can be conducted with target groups, such as Hispanic men 
and lesbian women, to inform the design and development of interventions. HPV 
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education messages should be tailored for these specific groups, and should incorporate 
qualitative results to determine strategic and informed options for education providers, 
locations, and approaches for intervention delivery. HPV interventions focused on 
Hispanic men should take into account the role of gender in Hispanic culture, and its 
intersection with class, nationality, sexual orientation, and religion to form the construct 
of “machismo.” 65 Constructs such as “machismo” in Hispanic men frame key health 
beliefs in Hispanic men and should be explored in future studies as a barrier to health 
seeking behavior, such as HPV vaccination.91,92 
As the intervention was implemented as a group with a purposive sample, the next 
step would be to implement the intervention as a randomized controlled trial with larger 
samples and in various settings. While the intervention was acceptable and efficacious in 
the classroom setting, future implementers should be prepared for additional or different 
barriers when studying diverse populations outside of this setting. Intervention 
investigators are more frequently utilizing online or mobile platforms for intervention 
delivery, which offer potential for impactful behavior change.93 While online 
interventions are cheap, innovative, easy to populate, and have the benefit of evolving 
with ongoing technological advances, they present new and unique challenges. Online or 
mobile interventions are more prone to high attrition rates than face-to-face interventions 
if the incentive is negligible. It is also difficult to assess the reach of the intervention, and 
effect sizes are often small or insignificant.94   
Future intervention research should consider incorporation of a third measurement 
point at a later date to assess long-term knowledge and attitude outcomes, and to 
determine if the intervention serves as a cue to action for HPV vaccination. The addition 
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of another measurement point would also be useful in assessing the strength of behavioral 
intention to vaccinate at baseline. 
Vaccine hesitant attitudes may be a dimension to consider in the endeavor to 
increase HPV vaccination, and is more difficult to diminish compared to lack of 
awareness or knowledge, which is relatively easy to remedy. Evidence has shown when 
vaccine hesitant parents were presented with risk-benefit information, their hesitant 
attitudes were strengthened instead of lessened.95 Participants of that study tended to 
focus on the segments of information which supported their hesitant views, while 
rejecting the information that supported vaccination. While the current intervention 
asserted only the safety and efficacy of the HPV vaccine, 10% participants holding 
hesitant vaccine attitudes were less likely to accept the information. These participants 
displayed attitude polarization that depended less on the intervention’s accuracy and 
more on whether the information supported their position.96 Future research can include 
increased measures of pre-existing vaccine attitudes to assess how hesitant attitudes can 
be deterred. HPV and other vaccine interventions should include educational materials 
designed to dispel vaccine myths and reduce judgement errors while concurrently 
promoting the vaccine. 
Finally, special consideration should be given to healthcare providers at all levels 
of the provider spectrum. Evidence points to provider recommendation as the single 
strongest event in the behavioral path to vaccination, with adolescents who received a 
recommendation five times more likely to receive a vaccination.97 Despite this, providers 
often do not suggest HPV vaccination with other routine adolescent vaccines, and are less 
likely to provide recommendations to racial/ethnic minorities. Future studies should 
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assess attitude and prejudicial predictors of HPV vaccination recommendations among 
healthcare providers. Medical education programs should also develop HPV and HPV 
vaccination educational modules to increase provider confidence in giving strong 
vaccination recommendations, especially in response to hesitant attitudes. As financial 
barriers to vaccination decrease due to policy and NGO efforts,90 attention should be 
turned to address non-financial barriers, such as lack of HPV knowledge, hesitant vaccine 
attitudes, and weak or optional provider recommendations. 
Conclusions 
No one intervention is efficacious enough to close all the gaps in HPV 
knowledge, attitudes, beliefs, and practices.84 Each intervention assesses and addresses 
different dimensions of awareness, knowledge, attitude, and behavior, and do so within 
the confines of specific populations. In this sense, the individual interventions are limited, 
but if strategically and synergistically placed, together can create a large impact. Public 
health professionals in education, academic, governmental and non-governmental sectors 
may increase multidisciplinary, collaborative efforts to achieve such impact. Further 
intervention is necessary for certain populations and at all ecological levels- individual, 
community, and policy- to alleviate the burden of HPV infection and reduce HPV-related 
cancers.  
A brief, educational intervention designed to improve HPV-related awareness, 
knowledge, and attitudes can be efficacious in changing attitudes and increasing 
knowledge among college students. Tailored and targeted HPV intervention is acceptable 
to sexually and ethnically diverse college students in south Florida, and may contribute to 
local and national goals to reduce HPV-related clinical outcomes. 
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Appendix B 
 
Questionnaire
MM/YYYY 
The EquiVax Project 
 
Thank you for agreeing to participate in our study.  It explores issues related to human papillomavirus (HPV).  
The survey is anonymous, and will take about 5 minutes to complete. If you’re unsure of what the correct 
answer is, please give us your best answer. 
 
First, a few questions about you.  Please respond to each of the following: 
 
1. What is the month and year of your birth? ________________ 
2. What is your gender? (Please circle one)  
(1) Male    (2) Female   (3) Transgender M to F   (4) Transgender F to M   (5) Other: __________ 
3. Ethnicity (please circle one): 
(1) Not Hispanic or Latino     (2) Hispanic or Latino    (3) Not sure or unknown 
4. Race (please circle all that apply): 
(1) American Indian or Alaska Native    (2) Asian/Pacific Islander    (3) Black/African American                                  
(4) White/Caucasian   (5) Not sure or unknown   (8) Other: ___________________________ 
5. Do you currently have any form of health insurance coverage? 
(1) Yes      (2) No      (3) Don’t Know  
6. Current relationship status (please circle one): 
(1) Single    (2) Married     (3) Divorced/Widowed    (4) In a Relationship   (5) Other: _________ 
7. Your sexual orientation (please circle one): 
(1) Heterosexual/straight     (2) Gay/Lesbian    (3) Bisexual     (4) Not sure     (5) Other: ________ 
8. Have you ever had: (circle yes or no for each) 
a.) Vaginal (penetrative) sex?     (1) Yes    (2) No 
b.) Oral sex?           (1) Yes    (2) No   
c.) Anal sex?      (1) Yes    (2) No 
9. How many different sex partners have you had in your lifetime  
(please circle one)?    
[0]     [1]      [2-5]      [6-10]      [11-15]      [>15] 
10. Have you heard of HPV or human papillomavirus before today  
(please circle one)?   
(1) Yes      (2) No      (3) Don’t Know 
11. How many doses of HPV vaccine have you received as of today  
(please circle one)?    
[0]      [1]      [2]      [3]      [Don’t know] 
12. If not already fully vaccinated against HPV, are you willing to take the HPV vaccine?  
(1) Yes      (2) No      (3) Don’t Know 
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Circle the number that best describes your knowledge 
or perception at this time. 
Nothing at all A 
little  
A 
moderate 
amount  
Quite a 
lot 
13. How much would you say you know about 
HPV or human papillomavirus? 
1 2 3 4 
14. How much would you say you know about 
HPV vaccine? 
1 2 3 4 
 
 
 
 
 
 
 
 
Please provide responses for each statement 
below.  Circle the number that best describes 
your agreement with each statement at this 
time. 
Strongly 
Agree 
Agre
e 
Neutr
al 
Disagree Stron
gly 
Disag
ree 
Don’t 
Know 
15. HPV infection is rare 1 2 3 4 5 6 
16. Only people who have sex with lots of 
other people get HPV 
1 2 3 4 5 6 
17. HPV is a serious health concern for 
women 
1 2 3 4 5 6 
18. HPV is a serious health concern for men 1 2 3 4 5 6 
19. HPV infection is a serious threat to my 
own health 
1 2 3 4 5 6 
20. I would be willing to use an anal swab 
on myself to screen for anal cancer 
1 2 3 4 5 6 
21. Vaccines in general are safe and 
effective 
1 2 3 4 5 6 
22. Women should be vaccinated against 
HPV 
1 2 3 4 5 6 
23. Men should be vaccinated against HPV 1 2 3 4 5 6 
24. Everyone should be vaccinated against 
HPV 
1 2 3 4   5 6 
25. My opinion of the HPV vaccine is 
mostly positive 
1 2 3 4   5 6 
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Please answer the following questions by circling True or False: 
26. The HPV virus causes herpes in men and women TRUE FALSE Don’t know 
27. HPV infection can cause genital warts TRUE FALSE Don’t know 
28. You can only get HPV from having sex TRUE FALSE Don’t know 
29. Acquired Immune Deficiency Syndrome (AIDS) is 
caused by human papillomavirus  
TRUE FALSE Don’t know 
30. The only way you can protect yourself from HPV is to 
use a condom 
TRUE FALSE Don’t know 
31. Some strains of HPV are harmless TRUE FALSE Don’t know 
32. HPV infection can cause cancer  TRUE FALSE Don’t know 
33. Before today, I never thought about asking about the 
HPV vaccine for myself 
TRUE FALSE Don’t know 
34. Student Health Services offers HPV vaccine TRUE FALSE Don’t know 
 
 
 
Please evaluate the presentation 
 
1. What did you think about the PowerPoint presentation (please circle one)? 
     (1) Too long    (2) Too short    (3) Just about right    (4) Other: ___________________________ 
2. How much information had you received about HPV before the presentation 
(please circle one)? 
      (1) None   (2) Very Little   (3) Some   (4) Quite a bit   (5) A great amount 
3. How useful was the question and answer session that followed the 
presentation (please circle one)? 
         (1) Very useful    (2) somewhat useful    (3) not very useful     (4) Not at all useful 
4. Please rate your overall assessment of today’s HPV educational experience 
(please circle one)? 
        (1) Very positive   (2) Positive   (3) Neutral    (4) Negative    (5) Very Negative    
5. How much did you learn from your participation (please circle one)? 
(1) Nothing     (2) Very Little    (3) Some things    (4) Quite a bit    (5) A great 
amount 
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B. Now about HPV.  Circle the number that best describes your knowledge or perception at this time. 
 
 
Extremely 
Knowledgeable 
Somewhat 
Knowledgeable 
Very Little 
Knowledge 
No 
Knowledge 
6.  How much would you say 
you know about HPV or 
human papillomavirus? 
1 2 3 4 
7.  How much would you say 
you know about the HPV 
vaccine? 
1 2 3 4 
 
 
Please provide responses for each 
statement below.  Circle the number 
that best describes your knowledge or 
feelings at this time. 
Strongly 
Agree 
Agree Neutral Disagree Strongl
y 
Disagre
e 
Don’t 
Know 
8.  HPV infection is rare 1 2 3 4 5 6 
9.  Only people who have sex with 
lots of other people get HPV 
1 2 3 4 5 6 
10. HPV is a serious concern for 
women 
1 2 3 4 5 6 
Please provide responses for each 
statement below.  Circle the number 
that best describes your knowledge or 
feelings at this time. 
Strongly 
Agree 
Agree Neutral Disagree Strongl
y 
Disagre
e 
Don’t 
Know 
11. HPV is a serious concern for men 1 2 3 4 5 6 
12. HPV infection is a serious threat 
to my own health 
1 2 3 4 5 6 
13. I would be willing to use an anal 
swab on myself to screen for anal 
cancer 
1 2 3 4 5 6 
14.  Vaccines in general are safe and 
effective 
1 2 3 4 5 6 
15. Women should be vaccinated 
against HPV 
1 2 3 4 5 6 
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Please answer the following questions by circling True or False regarding HPV: 
 
19. The HPV virus causes herpes in men and women TRUE FALSE 
20. HPV infection can cause genital warts TRUE FALSE 
21. You can only get HPV from having sex TRUE FALSE 
22. Acquired Immune Deficiency Syndrome (AIDS) is caused by human 
papillomavirus  
TRUE FALSE 
23. The only way you can protect yourself from HPV is to use a condom TRUE FALSE 
24. Some strains of HPV are harmless TRUE FALSE 
25. HPV infection can cause cancer  TRUE FALSE 
26. Before today, I never thought about asking about the HPV vaccine for 
myself 
TRUE FALSE 
27. Student Health Services offers HPV vaccine TRUE FALSE 
 
Major: _____________________________________                 
 
 
Thank you! 
 
 
  
16. Men should be vaccinated against 
HPV 
1 2 3 4 5 6 
17.  Everyone should be vaccinated 
against HPV 
1 2 3 4 5 6 
18. My opinion of the HPV vaccine is 
mostly positive 
1 2 3 4 5 6 
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